id	sid	tid	token	lemma	pos
cord-015493-vf4et613	1	1	key	key	JJ
cord-015493-vf4et613	2	1	:	:	:
cord-015493-vf4et613	2	2	cord-015493-vf4et613	cord-015493-vf4et613	NN
cord-015493-vf4et613	2	3	authors	author	NNS
cord-015493-vf4et613	2	4	:	:	:
cord-015493-vf4et613	3	1	Deresinski	Deresinski	NNP
cord-015493-vf4et613	3	2	,	,	,
cord-015493-vf4et613	3	3	Stan	Stan	NNP
cord-015493-vf4et613	3	4	title	title	NN
cord-015493-vf4et613	3	5	:	:	:
cord-015493-vf4et613	4	1	In	in	IN
cord-015493-vf4et613	4	2	the	the	DT
cord-015493-vf4et613	4	3	Literature	Literature	NNP
cord-015493-vf4et613	4	4	date	date	NN
cord-015493-vf4et613	4	5	:	:	:
cord-015493-vf4et613	4	6	2007	2007	CD
cord-015493-vf4et613	4	7	-	-	SYM
cord-015493-vf4et613	4	8	10	10	CD
cord-015493-vf4et613	4	9	-	-	SYM
cord-015493-vf4et613	4	10	15	15	CD
cord-015493-vf4et613	4	11	journal	journal	NN
cord-015493-vf4et613	4	12	:	:	:
cord-015493-vf4et613	5	1	Clin	Clin	NNP
cord-015493-vf4et613	5	2	Infect	infect	VB
cord-015493-vf4et613	5	3	Dis	Dis	NNP
cord-015493-vf4et613	5	4	DOI	doi	NN
cord-015493-vf4et613	5	5	:	:	:
cord-015493-vf4et613	6	1	10.1086/522526	10.1086/522526	CD
cord-015493-vf4et613	7	1	sha	sha	NNP
cord-015493-vf4et613	7	2	:	:	:
cord-015493-vf4et613	7	3	a37fb9ea168570a2eff4a857e233312dff92a3bb	a37fb9ea168570a2eff4a857e233312dff92a3bb	.
cord-015493-vf4et613	7	4	doc_id	doc_id	CD
cord-015493-vf4et613	7	5	:	:	:
cord-015493-vf4et613	7	6	15493	15493	CD
cord-015493-vf4et613	7	7	cord_uid	cord_uid	FW
cord-015493-vf4et613	7	8	:	:	:
cord-015493-vf4et613	8	1	vf4et613	vf4et613	NNP
cord-015493-vf4et613	8	2	nan	nan	NNP
cord-015493-vf4et613	9	1	After	after	IN
cord-015493-vf4et613	9	2	failing	fail	VBG
cord-015493-vf4et613	9	3	to	to	TO
cord-015493-vf4et613	9	4	detect	detect	VB
cord-015493-vf4et613	9	5	nucleic	nucleic	JJ
cord-015493-vf4et613	9	6	acid	acid	NN
cord-015493-vf4et613	9	7	of	of	IN
cord-015493-vf4et613	9	8	known	know	VBN
cord-015493-vf4et613	9	9	respiratory	respiratory	JJ
cord-015493-vf4et613	9	10	viruses	virus	NNS
cord-015493-vf4et613	9	11	in	in	IN
cord-015493-vf4et613	9	12	a	a	DT
cord-015493-vf4et613	9	13	nasopharyngeal	nasopharyngeal	JJ
cord-015493-vf4et613	9	14	aspirate	aspirate	NN
cord-015493-vf4et613	9	15	specimen	specimen	NN
cord-015493-vf4et613	9	16	obtained	obtain	VBN
cord-015493-vf4et613	9	17	from	from	IN
cord-015493-vf4et613	9	18	a	a	DT
cord-015493-vf4et613	9	19	3-year	3-year	CD
cord-015493-vf4et613	9	20	-	-	HYPH
cord-015493-vf4et613	9	21	old	old	JJ
cord-015493-vf4et613	9	22	child	child	NN
cord-015493-vf4et613	9	23	who	who	WP
cord-015493-vf4et613	9	24	had	have	VBD
cord-015493-vf4et613	9	25	been	be	VBN
cord-015493-vf4et613	9	26	hospitalized	hospitalize	VBN
cord-015493-vf4et613	9	27	in	in	IN
cord-015493-vf4et613	9	28	Brisbane	Brisbane	NNP
cord-015493-vf4et613	9	29	,	,	,
cord-015493-vf4et613	9	30	Australia	Australia	NNP
cord-015493-vf4et613	9	31	,	,	,
cord-015493-vf4et613	9	32	with	with	IN
cord-015493-vf4et613	9	33	pneumonia	pneumonia	NN
cord-015493-vf4et613	9	34	,	,	,
cord-015493-vf4et613	9	35	Gaynor	Gaynor	NNP
cord-015493-vf4et613	9	36	and	and	CC
cord-015493-vf4et613	9	37	colleagues	colleague	NNS
cord-015493-vf4et613	9	38	,	,	,
cord-015493-vf4et613	9	39	in	in	IN
cord-015493-vf4et613	9	40	a	a	DT
cord-015493-vf4et613	9	41	search	search	NN
cord-015493-vf4et613	9	42	for	for	IN
cord-015493-vf4et613	9	43	novel	novel	JJ
cord-015493-vf4et613	9	44	viral	viral	JJ
cord-015493-vf4et613	9	45	pathogens	pathogen	NNS
cord-015493-vf4et613	9	46	,	,	,
cord-015493-vf4et613	9	47	randomly	randomly	RB
cord-015493-vf4et613	9	48	amplified	amplify	VBD
cord-015493-vf4et613	9	49	and	and	CC
cord-015493-vf4et613	9	50	cloned	clone	VBD
cord-015493-vf4et613	9	51	total	total	JJ
cord-015493-vf4et613	9	52	nucleic	nucleic	JJ
cord-015493-vf4et613	9	53	acid	acid	NN
cord-015493-vf4et613	9	54	from	from	IN
cord-015493-vf4et613	9	55	the	the	DT
cord-015493-vf4et613	9	56	specimen	specimen	NN
cord-015493-vf4et613	9	57	.	.	.
cord-015493-vf4et613	10	1	They	-PRON-	PRP
cord-015493-vf4et613	10	2	then	then	RB
cord-015493-vf4et613	10	3	sequenced	sequence	VBD
cord-015493-vf4et613	10	4	a	a	DT
cord-015493-vf4et613	10	5	384well	384well	JJ
cord-015493-vf4et613	10	6	plate	plate	NN
cord-015493-vf4et613	10	7	of	of	IN
cord-015493-vf4et613	10	8	clones	clone	NNS
cord-015493-vf4et613	10	9	using	use	VBG
cord-015493-vf4et613	10	10	a	a	DT
cord-015493-vf4et613	10	11	universal	universal	JJ
cord-015493-vf4et613	10	12	primer	primer	NN
cord-015493-vf4et613	10	13	.	.	.
cord-015493-vf4et613	11	1	This	this	DT
cord-015493-vf4et613	11	2	yielded	yield	VBD
cord-015493-vf4et613	11	3	multiple	multiple	JJ
cord-015493-vf4et613	11	4	reads	read	NNS
cord-015493-vf4et613	11	5	,	,	,
cord-015493-vf4et613	11	6	6	6	CD
cord-015493-vf4et613	11	7	of	of	IN
cord-015493-vf4et613	11	8	which	which	WDT
cord-015493-vf4et613	11	9	were	be	VBD
cord-015493-vf4et613	11	10	of	of	IN
cord-015493-vf4et613	11	11	sequences	sequence	NNS
cord-015493-vf4et613	11	12	of	of	IN
cord-015493-vf4et613	11	13	a	a	DT
cord-015493-vf4et613	11	14	single	single	JJ
cord-015493-vf4et613	11	15	virus	virus	NN
cord-015493-vf4et613	11	16	.	.	.
cord-015493-vf4et613	12	1	Further	further	JJ
cord-015493-vf4et613	12	2	evaluation	evaluation	NN
cord-015493-vf4et613	12	3	of	of	IN
cord-015493-vf4et613	12	4	these	these	DT
cord-015493-vf4et613	12	5	sequences	sequence	NNS
cord-015493-vf4et613	12	6	demonstrated	demonstrate	VBD
cord-015493-vf4et613	12	7	homology	homology	NN
cord-015493-vf4et613	12	8	(	(	-LRB-
cord-015493-vf4et613	12	9	albeit	albeit	RB
cord-015493-vf4et613	12	10	limited	limited	JJ
cord-015493-vf4et613	12	11	)	)	-RRB-
cord-015493-vf4et613	12	12	to	to	IN
cord-015493-vf4et613	12	13	known	know	VBN
cord-015493-vf4et613	12	14	polyomaviruses	polyomaviruse	NNS
cord-015493-vf4et613	12	15	,	,	,
cord-015493-vf4et613	12	16	with	with	IN
cord-015493-vf4et613	12	17	the	the	DT
cord-015493-vf4et613	12	18	closest	close	JJS
cord-015493-vf4et613	12	19	relationship	relationship	NN
cord-015493-vf4et613	12	20	being	be	VBG
cord-015493-vf4et613	12	21	to	to	IN
cord-015493-vf4et613	12	22	KI	KI	NNP
cord-015493-vf4et613	12	23	,	,	,
cord-015493-vf4et613	12	24	a	a	DT
cord-015493-vf4et613	12	25	polyomavirus	polyomavirus	NN
cord-015493-vf4et613	12	26	that	that	WDT
cord-015493-vf4et613	12	27	had	have	VBD
cord-015493-vf4et613	12	28	recently	recently	RB
cord-015493-vf4et613	12	29	been	be	VBN
cord-015493-vf4et613	12	30	recovered	recover	VBN
cord-015493-vf4et613	12	31	from	from	IN
cord-015493-vf4et613	12	32	respiratory	respiratory	JJ
cord-015493-vf4et613	12	33	tract	tract	NN
cord-015493-vf4et613	12	34	samples	sample	NNS
cord-015493-vf4et613	12	35	from	from	IN
cord-015493-vf4et613	12	36	individuals	individual	NNS
cord-015493-vf4et613	12	37	with	with	IN
cord-015493-vf4et613	12	38	respiratory	respiratory	JJ
cord-015493-vf4et613	12	39	symptoms	symptom	NNS
cord-015493-vf4et613	12	40	[	[	-LRB-
cord-015493-vf4et613	12	41	1	1	CD
cord-015493-vf4et613	12	42	]	]	-RRB-
cord-015493-vf4et613	12	43	.	.	.
cord-015493-vf4et613	13	1	The	the	DT
cord-015493-vf4et613	13	2	newly	newly	RB
cord-015493-vf4et613	13	3	discovered	discover	VBN
cord-015493-vf4et613	13	4	virus	virus	NN
cord-015493-vf4et613	13	5	was	be	VBD
cord-015493-vf4et613	13	6	designated	designate	VBN
cord-015493-vf4et613	13	7	WU	WU	NNP
cord-015493-vf4et613	13	8	,	,	,
cord-015493-vf4et613	13	9	in	in	IN
cord-015493-vf4et613	13	10	keeping	keep	VBG
cord-015493-vf4et613	13	11	with	with	IN
cord-015493-vf4et613	13	12	the	the	DT
cord-015493-vf4et613	13	13	practice	practice	NN
cord-015493-vf4et613	13	14	of	of	IN
cord-015493-vf4et613	13	15	naming	name	VBG
cord-015493-vf4et613	13	16	polyomaviruses	polyomaviruse	NNS
cord-015493-vf4et613	13	17	with	with	IN
cord-015493-vf4et613	13	18	2-letter	2-letter	CD
cord-015493-vf4et613	13	19	designations	designation	NNS
cord-015493-vf4et613	13	20	(	(	-LRB-
cord-015493-vf4et613	13	21	e.g.	e.g.	RB
cord-015493-vf4et613	13	22	,	,	,
cord-015493-vf4et613	13	23	KI	KI	NNP
cord-015493-vf4et613	13	24	,	,	,
cord-015493-vf4et613	13	25	JC	JC	NNP
cord-015493-vf4et613	13	26	,	,	,
cord-015493-vf4et613	13	27	and	and	CC
cord-015493-vf4et613	13	28	BK	BK	NNP
cord-015493-vf4et613	13	29	)	)	-RRB-
cord-015493-vf4et613	13	30	.	.	.
cord-015493-vf4et613	14	1	Phylogenetic	phylogenetic	JJ
cord-015493-vf4et613	14	2	analysis	analysis	NN
cord-015493-vf4et613	14	3	demonstrated	demonstrate	VBD
cord-015493-vf4et613	14	4	that	that	IN
cord-015493-vf4et613	14	5	WU	WU	NNP
cord-015493-vf4et613	14	6	and	and	CC
cord-015493-vf4et613	14	7	KI	KI	NNP
cord-015493-vf4et613	14	8	are	be	VBP
cord-015493-vf4et613	14	9	divergent	divergent	JJ
cord-015493-vf4et613	14	10	from	from	IN
cord-015493-vf4et613	14	11	other	other	JJ
cord-015493-vf4et613	14	12	known	know	VBN
cord-015493-vf4et613	14	13	polyomaviruses	polyomaviruse	NNS
cord-015493-vf4et613	14	14	and	and	CC
cord-015493-vf4et613	14	15	define	define	VB
cord-015493-vf4et613	14	16	a	a	DT
cord-015493-vf4et613	14	17	novel	novel	JJ
cord-015493-vf4et613	14	18	branch	branch	NN
cord-015493-vf4et613	14	19	within	within	IN
cord-015493-vf4et613	14	20	this	this	DT
cord-015493-vf4et613	14	21	family	family	NN
cord-015493-vf4et613	14	22	.	.	.
cord-015493-vf4et613	15	1	WU	WU	NNP
cord-015493-vf4et613	15	2	was	be	VBD
cord-015493-vf4et613	15	3	detected	detect	VBN
cord-015493-vf4et613	15	4	by	by	IN
cord-015493-vf4et613	15	5	PCR	PCR	NNP
cord-015493-vf4et613	15	6	in	in	IN
cord-015493-vf4et613	15	7	37	37	CD
cord-015493-vf4et613	15	8	(	(	-LRB-
cord-015493-vf4et613	15	9	3.0	3.0	CD
cord-015493-vf4et613	15	10	%	%	NN
cord-015493-vf4et613	15	11	)	)	-RRB-
cord-015493-vf4et613	15	12	of	of	IN
cord-015493-vf4et613	15	13	1245	1245	CD
cord-015493-vf4et613	15	14	respiratory	respiratory	JJ
cord-015493-vf4et613	15	15	specimens	specimen	NNS
cord-015493-vf4et613	15	16	collected	collect	VBN
cord-015493-vf4et613	15	17	in	in	IN
cord-015493-vf4et613	15	18	Brisbane	Brisbane	NNP
cord-015493-vf4et613	15	19	in	in	IN
cord-015493-vf4et613	15	20	2003	2003	CD
cord-015493-vf4et613	15	21	and	and	CC
cord-015493-vf4et613	15	22	in	in	IN
cord-015493-vf4et613	15	23	5	5	CD
cord-015493-vf4et613	15	24	(	(	-LRB-
cord-015493-vf4et613	15	25	1.2	1.2	CD
cord-015493-vf4et613	15	26	%	%	NN
cord-015493-vf4et613	15	27	)	)	-RRB-
cord-015493-vf4et613	15	28	of	of	IN
cord-015493-vf4et613	15	29	410	410	CD
cord-015493-vf4et613	15	30	upper	upper	JJ
cord-015493-vf4et613	15	31	respiratory	respiratory	JJ
cord-015493-vf4et613	15	32	samples	sample	NNS
cord-015493-vf4et613	15	33	collected	collect	VBN
cord-015493-vf4et613	15	34	in	in	IN
cord-015493-vf4et613	15	35	St.	St.	NNP
cord-015493-vf4et613	15	36	Louis	Louis	NNP
cord-015493-vf4et613	15	37	,	,	,
cord-015493-vf4et613	15	38	Missouri	Missouri	NNP
cord-015493-vf4et613	15	39	,	,	,
cord-015493-vf4et613	15	40	as	as	RB
cord-015493-vf4et613	15	41	well	well	RB
cord-015493-vf4et613	15	42	as	as	IN
cord-015493-vf4et613	15	43	in	in	IN
cord-015493-vf4et613	15	44	1	1	CD
cord-015493-vf4et613	15	45	of	of	IN
cord-015493-vf4et613	15	46	480	480	CD
cord-015493-vf4et613	15	47	bronchoalveolar	bronchoalveolar	JJ
cord-015493-vf4et613	15	48	lavage	lavage	NN
cord-015493-vf4et613	15	49	samples	sample	NNS
cord-015493-vf4et613	15	50	obtained	obtain	VBN
cord-015493-vf4et613	15	51	mostly	mostly	RB
cord-015493-vf4et613	15	52	from	from	IN
cord-015493-vf4et613	15	53	adults	adult	NNS
cord-015493-vf4et613	15	54	,	,	,
cord-015493-vf4et613	15	55	also	also	RB
cord-015493-vf4et613	15	56	in	in	IN
cord-015493-vf4et613	15	57	St.	St.	NNP
cord-015493-vf4et613	15	58	Louis	Louis	NNP
cord-015493-vf4et613	15	59	.	.	.
cord-015493-vf4et613	16	1	In	in	IN
cord-015493-vf4et613	16	2	Brisbane	Brisbane	NNP
cord-015493-vf4et613	16	3	,	,	,
cord-015493-vf4et613	16	4	the	the	DT
cord-015493-vf4et613	16	5	samples	sample	NNS
cord-015493-vf4et613	16	6	yielding	yield	VBG
cord-015493-vf4et613	16	7	WU	WU	NNP
cord-015493-vf4et613	16	8	were	be	VBD
cord-015493-vf4et613	16	9	obtained	obtain	VBN
cord-015493-vf4et613	16	10	from	from	IN
cord-015493-vf4et613	16	11	individuals	individual	NNS
cord-015493-vf4et613	16	12	aged	age	VBN
cord-015493-vf4et613	16	13	from	from	IN
cord-015493-vf4et613	16	14	4	4	CD
cord-015493-vf4et613	16	15	months	month	NNS
cord-015493-vf4et613	16	16	to	to	IN
cord-015493-vf4et613	16	17	53	53	CD
cord-015493-vf4et613	16	18	years	year	NNS
cord-015493-vf4et613	16	19	,	,	,
cord-015493-vf4et613	16	20	although	although	IN
cord-015493-vf4et613	16	21	33	33	CD
cord-015493-vf4et613	16	22	of	of	IN
cord-015493-vf4et613	16	23	the	the	DT
cord-015493-vf4et613	16	24	37	37	CD
cord-015493-vf4et613	16	25	specimens	specimen	NNS
cord-015493-vf4et613	16	26	were	be	VBD
cord-015493-vf4et613	16	27	obtained	obtain	VBN
cord-015493-vf4et613	16	28	from	from	IN
cord-015493-vf4et613	16	29	persons	person	NNS
cord-015493-vf4et613	16	30	aged	age	VBN
cord-015493-vf4et613	16	31	р3	р3	NN
cord-015493-vf4et613	16	32	years	year	NNS
cord-015493-vf4et613	16	33	.	.	.
cord-015493-vf4et613	17	1	At	at	RB
cord-015493-vf4et613	17	2	least	least	JJS
cord-015493-vf4et613	17	3	3	3	CD
cord-015493-vf4et613	17	4	of	of	IN
cord-015493-vf4et613	17	5	the	the	DT
cord-015493-vf4et613	17	6	4	4	CD
cord-015493-vf4et613	17	7	adults	adult	NNS
cord-015493-vf4et613	17	8	in	in	IN
cord-015493-vf4et613	17	9	whom	whom	WP
cord-015493-vf4et613	17	10	WU	WU	NNP
cord-015493-vf4et613	17	11	was	be	VBD
cord-015493-vf4et613	17	12	detected	detect	VBN
cord-015493-vf4et613	17	13	were	be	VBD
cord-015493-vf4et613	17	14	signifi	signifi	NNP
cord-015493-vf4et613	17	15	-	-	HYPH
cord-015493-vf4et613	17	16	cantly	cantly	RB
cord-015493-vf4et613	17	17	immunocompromised	immunocompromised	JJ
cord-015493-vf4et613	17	18	,	,	,
cord-015493-vf4et613	17	19	and	and	CC
cord-015493-vf4et613	17	20	the	the	DT
cord-015493-vf4et613	17	21	fourth	fourth	JJ
cord-015493-vf4et613	17	22	had	have	VBD
cord-015493-vf4et613	17	23	cirrhosis	cirrhosis	NN
cord-015493-vf4et613	17	24	and	and	CC
cord-015493-vf4et613	17	25	was	be	VBD
cord-015493-vf4et613	17	26	undergoing	undergo	VBG
cord-015493-vf4et613	17	27	mechanically	mechanically	RB
cord-015493-vf4et613	17	28	ventilation	ventilation	NN
cord-015493-vf4et613	17	29	.	.	.
cord-015493-vf4et613	18	1	WU	WU	NNP
cord-015493-vf4et613	18	2	was	be	VBD
cord-015493-vf4et613	18	3	the	the	DT
cord-015493-vf4et613	18	4	only	only	JJ
cord-015493-vf4et613	18	5	virus	virus	NN
cord-015493-vf4et613	18	6	recovered	recover	VBN
cord-015493-vf4et613	18	7	from	from	IN
cord-015493-vf4et613	18	8	12	12	CD
cord-015493-vf4et613	18	9	patients	patient	NNS
cord-015493-vf4et613	18	10	,	,	,
cord-015493-vf4et613	18	11	whereas	whereas	IN
cord-015493-vf4et613	18	12	at	at	RB
cord-015493-vf4et613	18	13	least	least	JJS
cord-015493-vf4et613	18	14	1	1	CD
cord-015493-vf4et613	18	15	additional	additional	JJ
cord-015493-vf4et613	18	16	virus	virus	NN
cord-015493-vf4et613	18	17	was	be	VBD
cord-015493-vf4et613	18	18	detected	detect	VBN
cord-015493-vf4et613	18	19	in	in	IN
cord-015493-vf4et613	18	20	the	the	DT
cord-015493-vf4et613	18	21	other	other	JJ
cord-015493-vf4et613	18	22	25	25	CD
cord-015493-vf4et613	18	23	patients	patient	NNS
cord-015493-vf4et613	18	24	;	;	:
cord-015493-vf4et613	18	25	these	these	DT
cord-015493-vf4et613	18	26	included	include	VBN
cord-015493-vf4et613	18	27	rhinovirus	rhinovirus	NN
cord-015493-vf4et613	18	28	(	(	-LRB-
cord-015493-vf4et613	18	29	in	in	IN
cord-015493-vf4et613	18	30	15	15	CD
cord-015493-vf4et613	18	31	patients	patient	NNS
cord-015493-vf4et613	18	32	)	)	-RRB-
cord-015493-vf4et613	18	33	and	and	CC
cord-015493-vf4et613	18	34	human	human	JJ
cord-015493-vf4et613	18	35	bocavirus	bocavirus	NNP
cord-015493-vf4et613	18	36	(	(	-LRB-
cord-015493-vf4et613	18	37	in	in	IN
cord-015493-vf4et613	18	38	10	10	CD
cord-015493-vf4et613	18	39	patients	patient	NNS
cord-015493-vf4et613	18	40	)	)	-RRB-
cord-015493-vf4et613	18	41	.	.	.
cord-015493-vf4et613	19	1	Three	three	CD
cord-015493-vf4et613	19	2	viruses	virus	NNS
cord-015493-vf4et613	19	3	were	be	VBD
cord-015493-vf4et613	19	4	detected	detect	VBN
cord-015493-vf4et613	19	5	in	in	IN
cord-015493-vf4et613	19	6	6	6	CD
cord-015493-vf4et613	19	7	samples	sample	NNS
cord-015493-vf4et613	19	8	,	,	,
cord-015493-vf4et613	19	9	and	and	CC
cord-015493-vf4et613	19	10	1	1	CD
cord-015493-vf4et613	19	11	sample	sample	NN
cord-015493-vf4et613	19	12	contained	contain	VBN
cord-015493-vf4et613	19	13	4	4	CD
cord-015493-vf4et613	19	14	viruses	virus	NNS
cord-015493-vf4et613	19	15	(	(	-LRB-
cord-015493-vf4et613	19	16	WU	WU	NNP
cord-015493-vf4et613	19	17	,	,	,
cord-015493-vf4et613	19	18	bocavirus	bocavirus	NNP
cord-015493-vf4et613	19	19	,	,	,
cord-015493-vf4et613	19	20	rhinovirus	rhinovirus	NN
cord-015493-vf4et613	19	21	,	,	,
cord-015493-vf4et613	19	22	and	and	CC
cord-015493-vf4et613	19	23	adenovirus	adenovirus	NN
cord-015493-vf4et613	19	24	)	)	-RRB-
cord-015493-vf4et613	19	25	.	.	.
cord-015493-vf4et613	20	1	All	all	DT
cord-015493-vf4et613	20	2	6	6	CD
cord-015493-vf4et613	20	3	samples	sample	NNS
cord-015493-vf4et613	20	4	from	from	IN
cord-015493-vf4et613	20	5	St.	St.	NNP
cord-015493-vf4et613	20	6	Louis	Louis	NNP
cord-015493-vf4et613	20	7	that	that	WDT
cord-015493-vf4et613	20	8	contained	contain	VBD
cord-015493-vf4et613	20	9	WU	WU	NNP
cord-015493-vf4et613	20	10	yielded	yield	VBD
cord-015493-vf4et613	20	11	evidence	evidence	NN
cord-015493-vf4et613	20	12	of	of	IN
cord-015493-vf4et613	20	13	the	the	DT
cord-015493-vf4et613	20	14	presence	presence	NN
cord-015493-vf4et613	20	15	of	of	IN
cord-015493-vf4et613	20	16	an	an	DT
cord-015493-vf4et613	20	17	additional	additional	JJ
cord-015493-vf4et613	20	18	virus	virus	NN
cord-015493-vf4et613	20	19	.	.	.
cord-015493-vf4et613	21	1	Overall	overall	RB
cord-015493-vf4et613	21	2	,	,	,
cord-015493-vf4et613	21	3	72	72	CD
cord-015493-vf4et613	21	4	%	%	NN
cord-015493-vf4et613	21	5	of	of	IN
cord-015493-vf4et613	21	6	the	the	DT
cord-015493-vf4et613	21	7	samples	sample	NNS
cord-015493-vf4et613	21	8	that	that	WDT
cord-015493-vf4et613	21	9	contained	contain	VBD
cord-015493-vf4et613	21	10	WU	WU	NNP
cord-015493-vf4et613	21	11	had	have	VBD
cord-015493-vf4et613	21	12	evidence	evidence	NN
cord-015493-vf4et613	21	13	of	of	IN
cord-015493-vf4et613	21	14	coinfection	coinfection	NN
cord-015493-vf4et613	21	15	with	with	IN
cord-015493-vf4et613	21	16	у1	у1	JJ
cord-015493-vf4et613	21	17	additional	additional	JJ
cord-015493-vf4et613	21	18	virus	virus	NN
cord-015493-vf4et613	21	19	.	.	.
cord-015493-vf4et613	22	1	Because	because	IN
cord-015493-vf4et613	22	2	the	the	DT
cord-015493-vf4et613	22	3	BK	BK	NNP
cord-015493-vf4et613	22	4	and	and	CC
cord-015493-vf4et613	22	5	JC	JC	NNP
cord-015493-vf4et613	22	6	polyomaviruses	polyomaviruse	NNS
cord-015493-vf4et613	22	7	are	be	VBP
cord-015493-vf4et613	22	8	commonly	commonly	RB
cord-015493-vf4et613	22	9	found	find	VBN
cord-015493-vf4et613	22	10	in	in	IN
cord-015493-vf4et613	22	11	urine	urine	NN
cord-015493-vf4et613	22	12	specimens	specimen	NNS
cord-015493-vf4et613	22	13	,	,	,
cord-015493-vf4et613	22	14	501	501	CD
cord-015493-vf4et613	22	15	urine	urine	NN
cord-015493-vf4et613	22	16	samples	sample	NNS
cord-015493-vf4et613	22	17	obtained	obtain	VBN
cord-015493-vf4et613	22	18	from	from	IN
cord-015493-vf4et613	22	19	renal	renal	JJ
cord-015493-vf4et613	22	20	transplant	transplant	NN
cord-015493-vf4et613	22	21	recipients	recipient	NNS
cord-015493-vf4et613	22	22	in	in	IN
cord-015493-vf4et613	22	23	St.	St.	NNP
cord-015493-vf4et613	22	24	Louis	Louis	NNP
cord-015493-vf4et613	22	25	and	and	CC
cord-015493-vf4et613	22	26	226	226	CD
cord-015493-vf4et613	22	27	samples	sample	NNS
cord-015493-vf4et613	22	28	obtained	obtain	VBN
cord-015493-vf4et613	22	29	from	from	IN
cord-015493-vf4et613	22	30	patients	patient	NNS
cord-015493-vf4et613	22	31	in	in	IN
cord-015493-vf4et613	22	32	Brisbane	Brisbane	NNP
cord-015493-vf4et613	22	33	were	be	VBD
cord-015493-vf4et613	22	34	screened	screen	VBN
cord-015493-vf4et613	22	35	by	by	IN
cord-015493-vf4et613	22	36	PCR	PCR	NNP
cord-015493-vf4et613	22	37	;	;	:
cord-015493-vf4et613	22	38	none	none	NN
cord-015493-vf4et613	22	39	contained	contain	VBD
cord-015493-vf4et613	22	40	WU	WU	NNP
cord-015493-vf4et613	22	41	.	.	.
cord-015493-vf4et613	23	1	These	these	DT
cord-015493-vf4et613	23	2	findings	finding	NNS
cord-015493-vf4et613	23	3	suggest	suggest	VBP
cord-015493-vf4et613	23	4	-	-	:
cord-015493-vf4et613	23	5	but	but	CC
cord-015493-vf4et613	23	6	do	do	VBP
cord-015493-vf4et613	23	7	not	not	RB
cord-015493-vf4et613	23	8	prove	prove	VB
cord-015493-vf4et613	23	9	-	-	:
cord-015493-vf4et613	23	10	that	that	IN
cord-015493-vf4et613	23	11	this	this	DT
cord-015493-vf4et613	23	12	novel	novel	JJ
cord-015493-vf4et613	23	13	polyomavirus	polyomavirus	NNP
cord-015493-vf4et613	23	14	has	have	VBZ
cord-015493-vf4et613	23	15	a	a	DT
cord-015493-vf4et613	23	16	role	role	NN
cord-015493-vf4et613	23	17	in	in	IN
cord-015493-vf4et613	23	18	respiratory	respiratory	JJ
cord-015493-vf4et613	23	19	tract	tract	NN
cord-015493-vf4et613	23	20	infection	infection	NN
cord-015493-vf4et613	23	21	.	.	.
cord-015493-vf4et613	24	1	The	the	DT
cord-015493-vf4et613	24	2	very	very	RB
cord-015493-vf4et613	24	3	high	high	JJ
cord-015493-vf4et613	24	4	frequency	frequency	NN
cord-015493-vf4et613	24	5	of	of	IN
cord-015493-vf4et613	24	6	detection	detection	NN
cord-015493-vf4et613	24	7	of	of	IN
cord-015493-vf4et613	24	8	additional	additional	JJ
cord-015493-vf4et613	24	9	viruses	virus	NNS
cord-015493-vf4et613	24	10	,	,	,
cord-015493-vf4et613	24	11	which	which	WDT
cord-015493-vf4et613	24	12	were	be	VBD
cord-015493-vf4et613	24	13	detected	detect	VBN
cord-015493-vf4et613	24	14	in	in	IN
cord-015493-vf4et613	24	15	almost	almost	RB
cord-015493-vf4et613	24	16	three	three	CD
cord-015493-vf4et613	24	17	-	-	HYPH
cord-015493-vf4et613	24	18	fourths	fourth	NNS
cord-015493-vf4et613	24	19	of	of	IN
cord-015493-vf4et613	24	20	the	the	DT
cord-015493-vf4et613	24	21	patients	patient	NNS
cord-015493-vf4et613	24	22	,	,	,
cord-015493-vf4et613	24	23	complicates	complicate	VBZ
cord-015493-vf4et613	24	24	the	the	DT
cord-015493-vf4et613	24	25	analysis	analysis	NN
cord-015493-vf4et613	24	26	.	.	.
cord-015493-vf4et613	25	1	Nonetheless	nonetheless	RB
cord-015493-vf4et613	25	2	,	,	,
cord-015493-vf4et613	25	3	the	the	DT
cord-015493-vf4et613	25	4	frequency	frequency	NN
cord-015493-vf4et613	25	5	of	of	IN
cord-015493-vf4et613	25	6	its	-PRON-	PRP$
cord-015493-vf4et613	25	7	detection	detection	NN
cord-015493-vf4et613	25	8	in	in	IN
cord-015493-vf4et613	25	9	individuals	individual	NNS
cord-015493-vf4et613	25	10	(	(	-LRB-
cord-015493-vf4et613	25	11	especially	especially	RB
cord-015493-vf4et613	25	12	young	young	JJ
cord-015493-vf4et613	25	13	children	child	NNS
cord-015493-vf4et613	25	14	with	with	IN
cord-015493-vf4et613	25	15	respiratory	respiratory	JJ
cord-015493-vf4et613	25	16	symptoms	symptom	NNS
cord-015493-vf4et613	25	17	)	)	-RRB-
cord-015493-vf4et613	25	18	in	in	IN
cord-015493-vf4et613	25	19	2	2	CD
cord-015493-vf4et613	25	20	geographically	geographically	RB
cord-015493-vf4et613	25	21	distinct	distinct	JJ
cord-015493-vf4et613	25	22	areas	area	NNS
cord-015493-vf4et613	25	23	highly	highly	RB
cord-015493-vf4et613	25	24	suggests	suggest	VBZ
cord-015493-vf4et613	25	25	that	that	IN
cord-015493-vf4et613	25	26	it	-PRON-	PRP
cord-015493-vf4et613	25	27	is	be	VBZ
cord-015493-vf4et613	25	28	a	a	DT
cord-015493-vf4et613	25	29	cause	cause	NN
cord-015493-vf4et613	25	30	of	of	IN
cord-015493-vf4et613	25	31	human	human	JJ
cord-015493-vf4et613	25	32	disease	disease	NN
cord-015493-vf4et613	25	33	.	.	.
cord-015493-vf4et613	26	1	In	in	IN
cord-015493-vf4et613	26	2	the	the	DT
cord-015493-vf4et613	26	3	meantime	meantime	NN
cord-015493-vf4et613	26	4	,	,	,
cord-015493-vf4et613	26	5	we	-PRON-	PRP
cord-015493-vf4et613	26	6	can	can	MD
cord-015493-vf4et613	26	7	expect	expect	VB
cord-015493-vf4et613	26	8	the	the	DT
cord-015493-vf4et613	26	9	continued	continue	VBN
cord-015493-vf4et613	26	10	identification	identification	NN
cord-015493-vf4et613	26	11	of	of	IN
cord-015493-vf4et613	26	12	additional	additional	JJ
cord-015493-vf4et613	26	13	novel	novel	NN
cord-015493-vf4et613	26	14	viruses	virus	NNS
cord-015493-vf4et613	26	15	as	as	IN
cord-015493-vf4et613	26	16	candidate	candidate	NN
cord-015493-vf4et613	26	17	human	human	JJ
cord-015493-vf4et613	26	18	respiratory	respiratory	JJ
cord-015493-vf4et613	26	19	pathogens	pathogen	NNS
cord-015493-vf4et613	26	20	and	and	CC
cord-015493-vf4et613	26	21	can	can	MD
cord-015493-vf4et613	26	22	add	add	VB
cord-015493-vf4et613	26	23	WU	WU	NNP
cord-015493-vf4et613	26	24	,	,	,
cord-015493-vf4et613	26	25	along	along	IN
cord-015493-vf4et613	26	26	with	with	IN
cord-015493-vf4et613	26	27	the	the	DT
cord-015493-vf4et613	26	28	recently	recently	RB
cord-015493-vf4et613	26	29	identified	identify	VBN
cord-015493-vf4et613	26	30	rhinovirus	rhinovirus	NN
cord-015493-vf4et613	26	31	HRV	HRV	NNP
cord-015493-vf4et613	26	32	-	-	HYPH
cord-015493-vf4et613	26	33	QPM	QPM	NNP
cord-015493-vf4et613	26	34	[	[	-LRB-
cord-015493-vf4et613	26	35	2	2	CD
cord-015493-vf4et613	26	36	]	]	-RRB-
cord-015493-vf4et613	26	37	,	,	,
cord-015493-vf4et613	26	38	to	to	IN
cord-015493-vf4et613	26	39	the	the	DT
cord-015493-vf4et613	26	40	list	list	NN
cord-015493-vf4et613	26	41	of	of	IN
cord-015493-vf4et613	26	42	viruses	virus	NNS
cord-015493-vf4et613	26	43	identified	identify	VBN
cord-015493-vf4et613	26	44	in	in	IN
cord-015493-vf4et613	26	45	respiratory	respiratory	JJ
cord-015493-vf4et613	26	46	tract	tract	NN
cord-015493-vf4et613	26	47	specimens	specimen	NNS
cord-015493-vf4et613	26	48	since	since	IN
cord-015493-vf4et613	26	49	2001	2001	CD
cord-015493-vf4et613	26	50	:	:	:
cord-015493-vf4et613	26	51	human	human	NNP
cord-015493-vf4et613	26	52	metapneumovirus	metapneumovirus	NNP
cord-015493-vf4et613	26	53	,	,	,
cord-015493-vf4et613	26	54	severe	severe	JJ
cord-015493-vf4et613	26	55	acute	acute	JJ
cord-015493-vf4et613	26	56	respiratory	respiratory	JJ
cord-015493-vf4et613	26	57	syndrome	syndrome	NN
cord-015493-vf4et613	26	58	coronavirus	coronavirus	NN
cord-015493-vf4et613	26	59	,	,	,
cord-015493-vf4et613	26	60	coronaviruses	coronaviruse	NNS
cord-015493-vf4et613	26	61	NL63	NL63	NNP
cord-015493-vf4et613	26	62	and	and	CC
cord-015493-vf4et613	26	63	HKU1	HKU1	NNP
cord-015493-vf4et613	26	64	,	,	,
cord-015493-vf4et613	26	65	human	human	JJ
cord-015493-vf4et613	26	66	bocavirus	bocavirus	NN
cord-015493-vf4et613	26	67	,	,	,
cord-015493-vf4et613	26	68	KI	KI	NNP
cord-015493-vf4et613	26	69	polyomavirus	polyomavirus	NNP
cord-015493-vf4et613	26	70	,	,	,
cord-015493-vf4et613	26	71	and	and	CC
cord-015493-vf4et613	26	72	now	now	RB
cord-015493-vf4et613	26	73	HRV	HRV	NNP
cord-015493-vf4et613	26	74	-	-	HYPH
cord-015493-vf4et613	26	75	QPM	QPM	NNP
cord-015493-vf4et613	26	76	(	(	-LRB-
cord-015493-vf4et613	26	77	rhinovirus	rhinovirus	NN
cord-015493-vf4et613	26	78	)	)	-RRB-
cord-015493-vf4et613	26	79	and	and	CC
cord-015493-vf4et613	26	80	WU	WU	NNP
cord-015493-vf4et613	26	81	polyomavirus	polyomavirus	NNP
cord-015493-vf4et613	26	82	.	.	.
cord-015493-vf4et613	27	1	Ruhe	Ruhe	NNP
cord-015493-vf4et613	27	2	JJ	JJ	NNP
cord-015493-vf4et613	27	3	,	,	,
cord-015493-vf4et613	27	4	Menon	Menon	NNP
cord-015493-vf4et613	27	5	A.	A.	NNP
cord-015493-vf4et613	27	6	Tetracyclines	Tetracyclines	NNP
cord-015493-vf4et613	27	7	as	as	IN
cord-015493-vf4et613	27	8	an	an	DT
cord-015493-vf4et613	27	9	oral	oral	JJ
cord-015493-vf4et613	27	10	treatment	treatment	NN
cord-015493-vf4et613	27	11	option	option	NN
cord-015493-vf4et613	27	12	for	for	IN
cord-015493-vf4et613	27	13	patients	patient	NNS
cord-015493-vf4et613	27	14	with	with	IN
cord-015493-vf4et613	27	15	community	community	NN
cord-015493-vf4et613	27	16	-	-	HYPH
cord-015493-vf4et613	27	17	onset	onset	NN
cord-015493-vf4et613	27	18	methicillin	methicillin	NN
cord-015493-vf4et613	27	19	-	-	HYPH
cord-015493-vf4et613	27	20	resistant	resistant	JJ
cord-015493-vf4et613	27	21	Staphylococcus	Staphylococcus	NNP
cord-015493-vf4et613	27	22	aureus	aureus	NN
cord-015493-vf4et613	27	23	skin	skin	NN
cord-015493-vf4et613	27	24	and	and	CC
cord-015493-vf4et613	27	25	soft	soft	JJ
cord-015493-vf4et613	27	26	-	-	HYPH
cord-015493-vf4et613	27	27	tissue	tissue	NN
cord-015493-vf4et613	27	28	infections	infection	NNS
cord-015493-vf4et613	27	29	.	.	.
cord-015493-vf4et613	28	1	Antimicrob	Antimicrob	NNP
cord-015493-vf4et613	28	2	Agents	Agents	NNPS
cord-015493-vf4et613	28	3	Chemother	Chemother	NNP
cord-015493-vf4et613	28	4	2007	2007	CD
cord-015493-vf4et613	28	5	;	;	:
cord-015493-vf4et613	28	6	51:3298	51:3298	CD
cord-015493-vf4et613	28	7	-	-	SYM
cord-015493-vf4et613	28	8	303	303	CD
cord-015493-vf4et613	28	9	.	.	.
cord-015493-vf4et613	29	1	The	the	DT
cord-015493-vf4et613	29	2	role	role	NN
cord-015493-vf4et613	29	3	of	of	IN
cord-015493-vf4et613	29	4	antibiotics	antibiotic	NNS
cord-015493-vf4et613	29	5	in	in	IN
cord-015493-vf4et613	29	6	the	the	DT
cord-015493-vf4et613	29	7	treatment	treatment	NN
cord-015493-vf4et613	29	8	of	of	IN
cord-015493-vf4et613	29	9	uncomplicated	uncomplicated	JJ
cord-015493-vf4et613	29	10	SSTI	SSTI	NNP
cord-015493-vf4et613	29	11	due	due	IN
cord-015493-vf4et613	29	12	to	to	IN
cord-015493-vf4et613	29	13	community	community	NN
cord-015493-vf4et613	29	14	-	-	HYPH
cord-015493-vf4et613	29	15	acquired	acquire	VBN
cord-015493-vf4et613	29	16	MRSA	MRSA	NNP
cord-015493-vf4et613	29	17	has	have	VBZ
cord-015493-vf4et613	29	18	been	be	VBN
cord-015493-vf4et613	29	19	a	a	DT
cord-015493-vf4et613	29	20	matter	matter	NN
cord-015493-vf4et613	29	21	of	of	IN
cord-015493-vf4et613	29	22	dispute	dispute	NN
cord-015493-vf4et613	29	23	.	.	.
cord-015493-vf4et613	30	1	Early	early	JJ
cord-015493-vf4et613	30	2	reports	report	NNS
cord-015493-vf4et613	30	3	suggested	suggest	VBD
cord-015493-vf4et613	30	4	that	that	IN
cord-015493-vf4et613	30	5	incision	incision	NN
cord-015493-vf4et613	30	6	and	and	CC
cord-015493-vf4et613	30	7	drainage	drainage	NN
cord-015493-vf4et613	30	8	of	of	IN
cord-015493-vf4et613	30	9	cutaneous	cutaneous	JJ
cord-015493-vf4et613	30	10	abscesses	abscess	NNS
cord-015493-vf4et613	30	11	due	due	JJ
cord-015493-vf4et613	30	12	to	to	IN
cord-015493-vf4et613	30	13	community	community	NN
cord-015493-vf4et613	30	14	-	-	HYPH
cord-015493-vf4et613	30	15	acquired	acquire	VBN
cord-015493-vf4et613	30	16	MRSA	MRSA	NNP
cord-015493-vf4et613	30	17	was	be	VBD
cord-015493-vf4et613	30	18	sufficient	sufficient	JJ
cord-015493-vf4et613	30	19	,	,	,
cord-015493-vf4et613	30	20	at	at	IN
cord-015493-vf4et613	30	21	least	least	JJS
cord-015493-vf4et613	30	22	for	for	IN
cord-015493-vf4et613	30	23	abscesses	abscess	NNS
cord-015493-vf4et613	30	24	of	of	IN
cord-015493-vf4et613	30	25	relatively	relatively	RB
cord-015493-vf4et613	30	26	small	small	JJ
cord-015493-vf4et613	30	27	size	size	NN
cord-015493-vf4et613	30	28	.	.	.
cord-015493-vf4et613	31	1	Newer	new	JJR
cord-015493-vf4et613	31	2	,	,	,
cord-015493-vf4et613	31	3	more	more	RBR
cord-015493-vf4et613	31	4	convincing	convincing	JJ
cord-015493-vf4et613	31	5	evidence	evidence	NN
cord-015493-vf4et613	31	6	,	,	,
cord-015493-vf4et613	31	7	however	however	RB
cord-015493-vf4et613	31	8	,	,	,
cord-015493-vf4et613	31	9	appears	appear	VBZ
cord-015493-vf4et613	31	10	to	to	TO
cord-015493-vf4et613	31	11	indicate	indicate	VB
cord-015493-vf4et613	31	12	that	that	IN
cord-015493-vf4et613	31	13	antibiotic	antibiotic	JJ
cord-015493-vf4et613	31	14	treatment	treatment	NN
cord-015493-vf4et613	31	15	does	do	VBZ
cord-015493-vf4et613	31	16	matter	matter	NN
cord-015493-vf4et613	31	17	.	.	.
cord-015493-vf4et613	32	1	Ruhe	Ruhe	NNP
cord-015493-vf4et613	32	2	and	and	CC
cord-015493-vf4et613	32	3	colleagues	colleague	NNS
cord-015493-vf4et613	32	4	retrospectively	retrospectively	RB
cord-015493-vf4et613	32	5	examined	examine	VBD
cord-015493-vf4et613	32	6	the	the	DT
cord-015493-vf4et613	32	7	records	record	NNS
cord-015493-vf4et613	32	8	of	of	IN
cord-015493-vf4et613	32	9	282	282	CD
cord-015493-vf4et613	32	10	patients	patient	NNS
cord-015493-vf4et613	32	11	with	with	IN
cord-015493-vf4et613	32	12	282	282	CD
cord-015493-vf4et613	32	13	episodes	episode	NNS
cord-015493-vf4et613	32	14	of	of	IN
cord-015493-vf4et613	32	15	SSTI	SSTI	NNP
cord-015493-vf4et613	32	16	due	due	IN
cord-015493-vf4et613	32	17	to	to	IN
cord-015493-vf4et613	32	18	MRSA	MRSA	NNP
cord-015493-vf4et613	32	19	who	who	WP
cord-015493-vf4et613	32	20	presented	present	VBD
cord-015493-vf4et613	32	21	either	either	CC
cord-015493-vf4et613	32	22	to	to	IN
cord-015493-vf4et613	32	23	the	the	DT
cord-015493-vf4et613	32	24	emergency	emergency	NN
cord-015493-vf4et613	32	25	department	department	NN
cord-015493-vf4et613	32	26	or	or	CC
cord-015493-vf4et613	32	27	to	to	IN
cord-015493-vf4et613	32	28	the	the	DT
cord-015493-vf4et613	32	29	outpatient	outpatient	NN
cord-015493-vf4et613	32	30	clinic	clinic	NN
cord-015493-vf4et613	32	31	at	at	IN
cord-015493-vf4et613	32	32	2	2	CD
cord-015493-vf4et613	32	33	medical	medical	JJ
cord-015493-vf4et613	32	34	centers	center	NNS
cord-015493-vf4et613	32	35	during	during	IN
cord-015493-vf4et613	32	36	the	the	DT
cord-015493-vf4et613	32	37	period	period	NN
cord-015493-vf4et613	32	38	2002	2002	CD
cord-015493-vf4et613	32	39	-	-	SYM
cord-015493-vf4et613	32	40	2007	2007	CD
cord-015493-vf4et613	32	41	.	.	.
cord-015493-vf4et613	33	1	Three	three	CD
cord-015493-vf4et613	33	2	-	-	HYPH
cord-015493-vf4et613	33	3	fourths	fourth	NNS
cord-015493-vf4et613	33	4	of	of	IN
cord-015493-vf4et613	33	5	patients	patient	NNS
cord-015493-vf4et613	33	6	had	have	VBD
cord-015493-vf4et613	33	7	abscesses	abscess	NNS
cord-015493-vf4et613	33	8	,	,	,
cord-015493-vf4et613	33	9	13	13	CD
cord-015493-vf4et613	33	10	%	%	NN
cord-015493-vf4et613	33	11	had	have	VBD
cord-015493-vf4et613	33	12	furuncles	furuncle	NNS
cord-015493-vf4et613	33	13	or	or	CC
cord-015493-vf4et613	33	14	carbuncles	carbuncle	NNS
cord-015493-vf4et613	33	15	,	,	,
cord-015493-vf4et613	33	16	and	and	CC
cord-015493-vf4et613	33	17	12	12	CD
cord-015493-vf4et613	33	18	%	%	NN
cord-015493-vf4et613	33	19	had	have	VBD
cord-015493-vf4et613	33	20	cellulitis	cellulitis	NN
cord-015493-vf4et613	33	21	with	with	IN
cord-015493-vf4et613	33	22	a	a	DT
cord-015493-vf4et613	33	23	purulent	purulent	JJ
cord-015493-vf4et613	33	24	focus	focus	NN
cord-015493-vf4et613	33	25	.	.	.
cord-015493-vf4et613	34	1	The	the	DT
cord-015493-vf4et613	34	2	median	median	JJ
cord-015493-vf4et613	34	3	lesion	lesion	NN
cord-015493-vf4et613	34	4	maximum	maximum	JJ
cord-015493-vf4et613	34	5	diameter	diameter	NN
cord-015493-vf4et613	34	6	was	be	VBD
cord-015493-vf4et613	34	7	4	4	CD
cord-015493-vf4et613	34	8	cm	cm	NN
cord-015493-vf4et613	34	9	(	(	-LRB-
cord-015493-vf4et613	34	10	range	range	NN
cord-015493-vf4et613	34	11	,	,	,
cord-015493-vf4et613	34	12	3	3	CD
cord-015493-vf4et613	34	13	-	-	SYM
cord-015493-vf4et613	34	14	5	5	CD
cord-015493-vf4et613	34	15	cm	cm	NN
cord-015493-vf4et613	34	16	)	)	-RRB-
cord-015493-vf4et613	34	17	.	.	.
cord-015493-vf4et613	35	1	Incision	incision	NN
cord-015493-vf4et613	35	2	and	and	CC
cord-015493-vf4et613	35	3	drainage	drainage	NN
cord-015493-vf4et613	35	4	procedures	procedure	NNS
cord-015493-vf4et613	35	5	were	be	VBD
cord-015493-vf4et613	35	6	performed	perform	VBN
cord-015493-vf4et613	35	7	for	for	IN
cord-015493-vf4et613	35	8	91	91	CD
cord-015493-vf4et613	35	9	%	%	NN
cord-015493-vf4et613	35	10	of	of	IN
cord-015493-vf4et613	35	11	episodes	episode	NNS
cord-015493-vf4et613	35	12	with	with	IN
cord-015493-vf4et613	35	13	abscess	abscess	NN
cord-015493-vf4et613	35	14	,	,	,
cord-015493-vf4et613	35	15	furuncles	furuncle	NNS
cord-015493-vf4et613	35	16	,	,	,
cord-015493-vf4et613	35	17	or	or	CC
cord-015493-vf4et613	35	18	carbuncles	carbuncle	NNS
cord-015493-vf4et613	35	19	and	and	CC
cord-015493-vf4et613	35	20	for	for	IN
cord-015493-vf4et613	35	21	66	66	CD
cord-015493-vf4et613	35	22	%	%	NN
cord-015493-vf4et613	35	23	of	of	IN
cord-015493-vf4et613	35	24	the	the	DT
cord-015493-vf4et613	35	25	other	other	JJ
cord-015493-vf4et613	35	26	episodes	episode	NNS
cord-015493-vf4et613	35	27	.	.	.
cord-015493-vf4et613	36	1	For	for	IN
cord-015493-vf4et613	36	2	90	90	CD
cord-015493-vf4et613	36	3	episodes	episode	NNS
cord-015493-vf4et613	36	4	(	(	-LRB-
cord-015493-vf4et613	36	5	32	32	CD
cord-015493-vf4et613	36	6	%	%	NN
cord-015493-vf4et613	36	7	)	)	-RRB-
cord-015493-vf4et613	36	8	,	,	,
cord-015493-vf4et613	36	9	patients	patient	NNS
cord-015493-vf4et613	36	10	received	receive	VBD
cord-015493-vf4et613	36	11	doxycycline	doxycycline	NNP
cord-015493-vf4et613	36	12	(	(	-LRB-
cord-015493-vf4et613	36	13	)	)	-RRB-
cord-015493-vf4et613	36	14	or	or	CC
cord-015493-vf4et613	36	15	n	n	NN
cord-015493-vf4et613	36	16	p	p	NN
cord-015493-vf4et613	36	17	87	87	CD
cord-015493-vf4et613	36	18	minocycline	minocycline	NNP
cord-015493-vf4et613	36	19	(	(	-LRB-
cord-015493-vf4et613	36	20	)	)	-RRB-
cord-015493-vf4et613	36	21	,	,	,
cord-015493-vf4et613	36	22	whereas	whereas	IN
cord-015493-vf4et613	36	23	a	a	DT
cord-015493-vf4et613	36	24	b	b	NN
cord-015493-vf4et613	36	25	-	-	HYPH
cord-015493-vf4et613	36	26	lactam	lactam	NN
cord-015493-vf4et613	36	27	n	n	NN
cord-015493-vf4et613	36	28	p	p	NN
cord-015493-vf4et613	36	29	3	3	CD
cord-015493-vf4et613	36	30	antibiotic	antibiotic	NN
cord-015493-vf4et613	36	31	was	be	VBD
cord-015493-vf4et613	36	32	provided	provide	VBN
cord-015493-vf4et613	36	33	for	for	IN
cord-015493-vf4et613	36	34	the	the	DT
cord-015493-vf4et613	36	35	remaining	remain	VBG
cord-015493-vf4et613	36	36	episodes	episode	NNS
cord-015493-vf4et613	36	37	.	.	.
cord-015493-vf4et613	37	1	During	during	IN
cord-015493-vf4et613	37	2	the	the	DT
cord-015493-vf4et613	37	3	years	year	NNS
cord-015493-vf4et613	37	4	of	of	IN
cord-015493-vf4et613	37	5	the	the	DT
cord-015493-vf4et613	37	6	study	study	NN
cord-015493-vf4et613	37	7	,	,	,
cord-015493-vf4et613	37	8	94%-96	94%-96	CD
cord-015493-vf4et613	37	9	%	%	NN
cord-015493-vf4et613	37	10	of	of	IN
cord-015493-vf4et613	37	11	isolates	isolate	NNS
cord-015493-vf4et613	37	12	were	be	VBD
cord-015493-vf4et613	37	13	found	find	VBN
cord-015493-vf4et613	37	14	to	to	TO
cord-015493-vf4et613	37	15	be	be	VB
cord-015493-vf4et613	37	16	susceptible	susceptible	JJ
cord-015493-vf4et613	37	17	to	to	IN
cord-015493-vf4et613	37	18	tetracycline	tetracycline	NNP
cord-015493-vf4et613	37	19	.	.	.
cord-015493-vf4et613	38	1	Ten	ten	CD
cord-015493-vf4et613	38	2	percent	percent	NN
cord-015493-vf4et613	38	3	of	of	IN
cord-015493-vf4et613	38	4	patients	patient	NNS
cord-015493-vf4et613	38	5	experienced	experience	VBD
cord-015493-vf4et613	38	6	treatment	treatment	NN
cord-015493-vf4et613	38	7	failure	failure	NN
cord-015493-vf4et613	38	8	,	,	,
cord-015493-vf4et613	38	9	with	with	IN
cord-015493-vf4et613	38	10	23	23	CD
cord-015493-vf4et613	38	11	requiring	require	VBG
cord-015493-vf4et613	38	12	a	a	DT
cord-015493-vf4et613	38	13	second	second	JJ
cord-015493-vf4et613	38	14	incision	incision	NN
cord-015493-vf4et613	38	15	and	and	CC
cord-015493-vf4et613	38	16	drainage	drainage	NN
cord-015493-vf4et613	38	17	procedure	procedure	NN
cord-015493-vf4et613	38	18	and	and	CC
cord-015493-vf4et613	38	19	5	5	CD
cord-015493-vf4et613	38	20	requiring	require	VBG
cord-015493-vf4et613	38	21	hospital	hospital	NN
cord-015493-vf4et613	38	22	admission	admission	NN
cord-015493-vf4et613	38	23	.	.	.
cord-015493-vf4et613	39	1	In	in	IN
cord-015493-vf4et613	39	2	contrast	contrast	NN
cord-015493-vf4et613	39	3	to	to	IN
cord-015493-vf4et613	39	4	previous	previous	JJ
cord-015493-vf4et613	39	5	reports	report	NNS
cord-015493-vf4et613	39	6	,	,	,
cord-015493-vf4et613	39	7	the	the	DT
cord-015493-vf4et613	39	8	size	size	NN
cord-015493-vf4et613	39	9	of	of	IN
cord-015493-vf4et613	39	10	the	the	DT
cord-015493-vf4et613	39	11	lesion	lesion	NN
cord-015493-vf4et613	39	12	was	be	VBD
cord-015493-vf4et613	39	13	not	not	RB
cord-015493-vf4et613	39	14	associated	associate	VBN
cord-015493-vf4et613	39	15	with	with	IN
cord-015493-vf4et613	39	16	outcome	outcome	NN
cord-015493-vf4et613	39	17	.	.	.
cord-015493-vf4et613	40	1	Logistic	logistic	JJ
cord-015493-vf4et613	40	2	regression	regression	NN
cord-015493-vf4et613	40	3	analysis	analysis	NN
cord-015493-vf4et613	40	4	identified	identify	VBD
cord-015493-vf4et613	40	5	receipt	receipt	NN
cord-015493-vf4et613	40	6	of	of	IN
cord-015493-vf4et613	40	7	a	a	DT
cord-015493-vf4et613	40	8	b	b	NN
cord-015493-vf4et613	40	9	-	-	HYPH
cord-015493-vf4et613	40	10	lactam	lactam	NNS
cord-015493-vf4et613	40	11	antibiotic	antibiotic	NN
cord-015493-vf4et613	40	12	as	as	IN
cord-015493-vf4et613	40	13	the	the	DT
cord-015493-vf4et613	40	14	only	only	JJ
cord-015493-vf4et613	40	15	clinical	clinical	JJ
cord-015493-vf4et613	40	16	predictor	predictor	NN
cord-015493-vf4et613	40	17	of	of	IN
cord-015493-vf4et613	40	18	treatment	treatment	NN
cord-015493-vf4et613	40	19	failure	failure	NN
cord-015493-vf4et613	40	20	(	(	-LRB-
cord-015493-vf4et613	40	21	adjusted	adjust	VBN
cord-015493-vf4et613	40	22	OR	or	CC
cord-015493-vf4et613	40	23	,	,	,
cord-015493-vf4et613	40	24	3.94	3.94	CD
cord-015493-vf4et613	40	25	;	;	:
cord-015493-vf4et613	40	26	95	95	CD
cord-015493-vf4et613	40	27	%	%	NN
cord-015493-vf4et613	40	28	CI	ci	NN
cord-015493-vf4et613	40	29	,	,	,
cord-015493-vf4et613	40	30	1.28	1.28	CD
cord-015493-vf4et613	40	31	-	-	SYM
cord-015493-vf4et613	40	32	12.15	12.15	CD
cord-015493-vf4et613	40	33	)	)	-RRB-
cord-015493-vf4et613	40	34	.	.	.
cord-015493-vf4et613	41	1	Subgroup	subgroup	NN
cord-015493-vf4et613	41	2	analysis	analysis	NN
cord-015493-vf4et613	41	3	that	that	WDT
cord-015493-vf4et613	41	4	included	include	VBD
cord-015493-vf4et613	41	5	only	only	RB
cord-015493-vf4et613	41	6	the	the	DT
cord-015493-vf4et613	41	7	225	225	CD
cord-015493-vf4et613	41	8	episodes	episode	NNS
cord-015493-vf4et613	41	9	in	in	IN
cord-015493-vf4et613	41	10	which	which	WDT
cord-015493-vf4et613	41	11	incision	incision	NN
cord-015493-vf4et613	41	12	and	and	CC
cord-015493-vf4et613	41	13	drainage	drainage	NN
cord-015493-vf4et613	41	14	were	be	VBD
cord-015493-vf4et613	41	15	performed	perform	VBN
cord-015493-vf4et613	41	16	at	at	IN
cord-015493-vf4et613	41	17	presentation	presentation	NN
cord-015493-vf4et613	41	18	confirmed	confirm	VBD
cord-015493-vf4et613	41	19	that	that	IN
cord-015493-vf4et613	41	20	blactam	blactam	NNP
cord-015493-vf4et613	41	21	antibiotic	antibiotic	JJ
cord-015493-vf4et613	41	22	therapy	therapy	NN
cord-015493-vf4et613	41	23	was	be	VBD
cord-015493-vf4et613	41	24	significantly	significantly	RB
cord-015493-vf4et613	41	25	associated	associate	VBN
cord-015493-vf4et613	41	26	with	with	IN
cord-015493-vf4et613	41	27	treatment	treatment	NN
cord-015493-vf4et613	41	28	failure	failure	NN
cord-015493-vf4et613	41	29	.	.	.
cord-015493-vf4et613	42	1	These	these	DT
cord-015493-vf4et613	42	2	results	result	NNS
cord-015493-vf4et613	42	3	are	be	VBP
cord-015493-vf4et613	42	4	consistent	consistent	JJ
cord-015493-vf4et613	42	5	with	with	IN
cord-015493-vf4et613	42	6	those	those	DT
cord-015493-vf4et613	42	7	of	of	IN
cord-015493-vf4et613	42	8	several	several	JJ
cord-015493-vf4et613	42	9	other	other	JJ
cord-015493-vf4et613	42	10	recent	recent	JJ
cord-015493-vf4et613	42	11	studies	study	NNS
cord-015493-vf4et613	42	12	that	that	WDT
cord-015493-vf4et613	42	13	have	have	VBP
cord-015493-vf4et613	42	14	found	find	VBN
cord-015493-vf4et613	42	15	that	that	IN
cord-015493-vf4et613	42	16	administration	administration	NN
cord-015493-vf4et613	42	17	of	of	IN
cord-015493-vf4et613	42	18	an	an	DT
cord-015493-vf4et613	42	19	antibiotic	antibiotic	NN
cord-015493-vf4et613	42	20	that	that	WDT
cord-015493-vf4et613	42	21	inhibits	inhibit	VBZ
cord-015493-vf4et613	42	22	the	the	DT
cord-015493-vf4et613	42	23	growth	growth	NN
cord-015493-vf4et613	42	24	of	of	IN
cord-015493-vf4et613	42	25	MRSA	MRSA	NNP
cord-015493-vf4et613	42	26	improves	improve	VBZ
cord-015493-vf4et613	42	27	outcomes	outcome	NNS
cord-015493-vf4et613	42	28	,	,	,
cord-015493-vf4et613	42	29	even	even	RB
cord-015493-vf4et613	42	30	in	in	IN
cord-015493-vf4et613	42	31	patients	patient	NNS
cord-015493-vf4et613	42	32	who	who	WP
cord-015493-vf4et613	42	33	have	have	VBP
cord-015493-vf4et613	42	34	undergone	undergo	VBN
cord-015493-vf4et613	42	35	incision	incision	NN
cord-015493-vf4et613	42	36	and	and	CC
cord-015493-vf4et613	42	37	drainage	drainage	NN
cord-015493-vf4et613	42	38	.	.	.
cord-015493-vf4et613	43	1	For	for	IN
cord-015493-vf4et613	43	2	example	example	NN
cord-015493-vf4et613	43	3	,	,	,
cord-015493-vf4et613	43	4	in	in	IN
cord-015493-vf4et613	43	5	a	a	DT
cord-015493-vf4et613	43	6	similar	similar	JJ
cord-015493-vf4et613	43	7	retrospective	retrospective	JJ
cord-015493-vf4et613	43	8	study	study	NN
cord-015493-vf4et613	43	9	of	of	IN
cord-015493-vf4et613	43	10	531	531	CD
cord-015493-vf4et613	43	11	episodes	episode	NNS
cord-015493-vf4et613	43	12	of	of	IN
cord-015493-vf4et613	43	13	community	community	NN
cord-015493-vf4et613	43	14	-	-	HYPH
cord-015493-vf4et613	43	15	acquired	acquire	VBN
cord-015493-vf4et613	43	16	MRSA	MRSA	NNP
cord-015493-vf4et613	43	17	SSTI	SSTI	NNP
cord-015493-vf4et613	43	18	,	,	,
cord-015493-vf4et613	43	19	most	most	JJS
cord-015493-vf4et613	43	20	of	of	IN
cord-015493-vf4et613	43	21	which	which	WDT
cord-015493-vf4et613	43	22	were	be	VBD
cord-015493-vf4et613	43	23	treated	treat	VBN
cord-015493-vf4et613	43	24	with	with	IN
cord-015493-vf4et613	43	25	incision	incision	NN
cord-015493-vf4et613	43	26	and	and	CC
cord-015493-vf4et613	43	27	drainage	drainage	NN
cord-015493-vf4et613	43	28	,	,	,
cord-015493-vf4et613	43	29	Ruhe	Ruhe	NNP
cord-015493-vf4et613	43	30	et	et	NNP
cord-015493-vf4et613	43	31	al	al	NNP
cord-015493-vf4et613	43	32	.	.	.
cord-015493-vf4et613	44	1	[	[	-LRB-
cord-015493-vf4et613	44	2	1	1	LS
cord-015493-vf4et613	44	3	]	]	-RRB-
cord-015493-vf4et613	44	4	found	find	VBD
cord-015493-vf4et613	44	5	treatment	treatment	NN
cord-015493-vf4et613	44	6	failure	failure	NN
cord-015493-vf4et613	44	7	rates	rate	NNS
cord-015493-vf4et613	44	8	of	of	IN
cord-015493-vf4et613	44	9	5	5	CD
cord-015493-vf4et613	44	10	%	%	NN
cord-015493-vf4et613	44	11	among	among	IN
cord-015493-vf4et613	44	12	patients	patient	NNS
cord-015493-vf4et613	44	13	who	who	WP
cord-015493-vf4et613	44	14	received	receive	VBD
cord-015493-vf4et613	44	15	an	an	DT
cord-015493-vf4et613	44	16	antibiotic	antibiotic	JJ
cord-015493-vf4et613	44	17	active	active	JJ
cord-015493-vf4et613	44	18	against	against	IN
cord-015493-vf4et613	44	19	the	the	DT
cord-015493-vf4et613	44	20	pathogen	pathogen	NN
cord-015493-vf4et613	44	21	and	and	CC
cord-015493-vf4et613	44	22	13	13	CD
cord-015493-vf4et613	44	23	%	%	NN
cord-015493-vf4et613	44	24	among	among	IN
cord-015493-vf4et613	44	25	those	those	DT
cord-015493-vf4et613	44	26	who	who	WP
cord-015493-vf4et613	44	27	received	receive	VBD
cord-015493-vf4et613	44	28	an	an	DT
cord-015493-vf4et613	44	29	antibiotic	antibiotic	NN
cord-015493-vf4et613	44	30	without	without	IN
cord-015493-vf4et613	44	31	activity	activity	NN
cord-015493-vf4et613	44	32	(	(	-LRB-
cord-015493-vf4et613	44	33	)	)	-RRB-
cord-015493-vf4et613	44	34	.	.	.
cord-015493-vf4et613	45	1	There	there	EX
cord-015493-vf4et613	45	2	has	have	VBZ
cord-015493-vf4et613	45	3	been	be	VBN
cord-015493-vf4et613	45	4	little	little	JJ
cord-015493-vf4et613	45	5	P	p	NN
cord-015493-vf4et613	45	6	p	p	NN
cord-015493-vf4et613	45	7	.01	.01	CD
cord-015493-vf4et613	45	8	study	study	NN
cord-015493-vf4et613	45	9	of	of	IN
cord-015493-vf4et613	45	10	which	which	WDT
cord-015493-vf4et613	45	11	antibiotic	antibiotic	JJ
cord-015493-vf4et613	45	12	with	with	IN
cord-015493-vf4et613	45	13	activity	activity	NN
cord-015493-vf4et613	45	14	against	against	IN
cord-015493-vf4et613	45	15	MRSA	MRSA	NNP
cord-015493-vf4et613	45	16	is	be	VBZ
cord-015493-vf4et613	45	17	optimum	optimum	JJ
cord-015493-vf4et613	45	18	.	.	.
cord-015493-vf4et613	46	1	Although	although	IN
cord-015493-vf4et613	46	2	Ruhe	Ruhe	NNP
cord-015493-vf4et613	46	3	and	and	CC
cord-015493-vf4et613	46	4	colleagues	colleague	NNS
cord-015493-vf4et613	46	5	provide	provide	VBP
cord-015493-vf4et613	46	6	evidence	evidence	NN
cord-015493-vf4et613	46	7	of	of	IN
cord-015493-vf4et613	46	8	the	the	DT
cord-015493-vf4et613	46	9	benefit	benefit	NN
cord-015493-vf4et613	46	10	of	of	IN
cord-015493-vf4et613	46	11	doxycyline	doxycyline	NN
cord-015493-vf4et613	46	12	for	for	IN
cord-015493-vf4et613	46	13	the	the	DT
cord-015493-vf4et613	46	14	treatment	treatment	NN
cord-015493-vf4et613	46	15	of	of	IN
cord-015493-vf4et613	46	16	SSTI	SSTI	NNP
cord-015493-vf4et613	46	17	due	due	IN
cord-015493-vf4et613	46	18	to	to	IN
cord-015493-vf4et613	46	19	antibioticsusceptible	antibioticsusceptible	JJ
cord-015493-vf4et613	46	20	MRSA	MRSA	NNP
cord-015493-vf4et613	46	21	,	,	,
cord-015493-vf4et613	46	22	alternative	alternative	JJ
cord-015493-vf4et613	46	23	antibiotic	antibiotic	JJ
cord-015493-vf4et613	46	24	choices	choice	NNS
cord-015493-vf4et613	46	25	may	may	MD
cord-015493-vf4et613	46	26	be	be	VB
cord-015493-vf4et613	46	27	considered	consider	VBN
cord-015493-vf4et613	46	28	.	.	.
cord-015493-vf4et613	47	1	In	in	IN
cord-015493-vf4et613	47	2	a	a	DT
cord-015493-vf4et613	47	3	small	small	JJ
cord-015493-vf4et613	47	4	,	,	,
cord-015493-vf4et613	47	5	prospective	prospective	JJ
cord-015493-vf4et613	47	6	,	,	,
cord-015493-vf4et613	47	7	open	open	JJ
cord-015493-vf4et613	47	8	-	-	HYPH
cord-015493-vf4et613	47	9	label	label	NN
cord-015493-vf4et613	47	10	trial	trial	NN
cord-015493-vf4et613	47	11	,	,	,
cord-015493-vf4et613	47	12	outpatients	outpatient	NNS
cord-015493-vf4et613	47	13	with	with	IN
cord-015493-vf4et613	47	14	SSTI	SSTI	NNP
cord-015493-vf4et613	47	15	were	be	VBD
cord-015493-vf4et613	47	16	randomized	randomize	VBN
cord-015493-vf4et613	47	17	to	to	TO
cord-015493-vf4et613	47	18	receive	receive	VB
cord-015493-vf4et613	47	19	treatment	treatment	NN
cord-015493-vf4et613	47	20	with	with	IN
cord-015493-vf4et613	47	21	either	either	CC
cord-015493-vf4et613	47	22	trimethoprim	trimethoprim	NNP
cord-015493-vf4et613	47	23	-	-	HYPH
cord-015493-vf4et613	47	24	sulfamethoxazole	sulfamethoxazole	NNP
cord-015493-vf4et613	47	25	(	(	-LRB-
cord-015493-vf4et613	47	26	160	160	CD
cord-015493-vf4et613	47	27	mg/800	mg/800	NNP
cord-015493-vf4et613	47	28	mg	mg	NNP
cord-015493-vf4et613	47	29	)	)	-RRB-
cord-015493-vf4et613	47	30	or	or	CC
cord-015493-vf4et613	47	31	doxycycline	doxycycline	NNP
cord-015493-vf4et613	47	32	(	(	-LRB-
cord-015493-vf4et613	47	33	100	100	CD
cord-015493-vf4et613	47	34	mg	mg	NNP
cord-015493-vf4et613	47	35	)	)	-RRB-
cord-015493-vf4et613	47	36	,	,	,
cord-015493-vf4et613	47	37	each	each	DT
cord-015493-vf4et613	47	38	given	give	VBN
cord-015493-vf4et613	47	39	twice	twice	RB
cord-015493-vf4et613	47	40	daily	daily	RB
cord-015493-vf4et613	47	41	for	for	IN
cord-015493-vf4et613	47	42	7	7	CD
cord-015493-vf4et613	47	43	days	day	NNS
cord-015493-vf4et613	47	44	[	[	-LRB-
cord-015493-vf4et613	47	45	2	2	CD
cord-015493-vf4et613	47	46	]	]	-RRB-
cord-015493-vf4et613	47	47	.	.	.
cord-015493-vf4et613	48	1	Although	although	IN
cord-015493-vf4et613	48	2	there	there	EX
cord-015493-vf4et613	48	3	was	be	VBD
cord-015493-vf4et613	48	4	not	not	RB
cord-015493-vf4et613	48	5	a	a	DT
cord-015493-vf4et613	48	6	statistically	statistically	RB
cord-015493-vf4et613	48	7	significant	significant	JJ
cord-015493-vf4et613	48	8	difference	difference	NN
cord-015493-vf4et613	48	9	in	in	IN
cord-015493-vf4et613	48	10	outcome	outcome	NN
cord-015493-vf4et613	48	11	,	,	,
cord-015493-vf4et613	48	12	all	all	DT
cord-015493-vf4et613	48	13	3	3	CD
cord-015493-vf4et613	48	14	treatment	treatment	NN
cord-015493-vf4et613	48	15	failures	failure	NNS
cord-015493-vf4et613	48	16	occurred	occur	VBD
cord-015493-vf4et613	48	17	among	among	IN
cord-015493-vf4et613	48	18	the	the	DT
cord-015493-vf4et613	48	19	14	14	CD
cord-015493-vf4et613	48	20	patients	patient	NNS
cord-015493-vf4et613	48	21	who	who	WP
cord-015493-vf4et613	48	22	received	receive	VBD
cord-015493-vf4et613	48	23	trimethoprim	trimethoprim	NNP
cord-015493-vf4et613	48	24	-	-	HYPH
cord-015493-vf4et613	48	25	sulfamethoxazole	sulfamethoxazole	NNP
cord-015493-vf4et613	48	26	,	,	,
cord-015493-vf4et613	48	27	for	for	IN
cord-015493-vf4et613	48	28	a	a	DT
cord-015493-vf4et613	48	29	treat	treat	NN
cord-015493-vf4et613	48	30	-	-	HYPH
cord-015493-vf4et613	48	31	ment	ment	NN
cord-015493-vf4et613	48	32	failure	failure	NN
cord-015493-vf4et613	48	33	rate	rate	NN
cord-015493-vf4et613	48	34	of	of	IN
cord-015493-vf4et613	48	35	21	21	CD
cord-015493-vf4et613	48	36	%	%	NN
cord-015493-vf4et613	48	37	.	.	.
cord-015493-vf4et613	49	1	The	the	DT
cord-015493-vf4et613	49	2	optimal	optimal	JJ
cord-015493-vf4et613	49	3	antibiotic	antibiotic	JJ
cord-015493-vf4et613	49	4	choice	choice	NN
cord-015493-vf4et613	49	5	thus	thus	RB
cord-015493-vf4et613	49	6	awaits	await	VBZ
cord-015493-vf4et613	49	7	results	result	NNS
cord-015493-vf4et613	49	8	of	of	IN
cord-015493-vf4et613	49	9	future	future	JJ
cord-015493-vf4et613	49	10	clinical	clinical	JJ
cord-015493-vf4et613	49	11	trials	trial	NNS
cord-015493-vf4et613	49	12	with	with	IN
cord-015493-vf4et613	49	13	sample	sample	NN
cord-015493-vf4et613	49	14	sizes	size	NNS
cord-015493-vf4et613	49	15	sufficient	sufficient	JJ
cord-015493-vf4et613	49	16	to	to	TO
cord-015493-vf4et613	49	17	allow	allow	VB
cord-015493-vf4et613	49	18	for	for	IN
cord-015493-vf4et613	49	19	definitive	definitive	JJ
cord-015493-vf4et613	49	20	answers	answer	NNS
cord-015493-vf4et613	49	21	.	.	.
cord-015493-vf4et613	50	1	One	one	CD
cord-015493-vf4et613	50	2	problem	problem	NN
cord-015493-vf4et613	50	3	,	,	,
cord-015493-vf4et613	50	4	however	however	RB
cord-015493-vf4et613	50	5	,	,	,
cord-015493-vf4et613	50	6	is	be	VBZ
cord-015493-vf4et613	50	7	that	that	IN
cord-015493-vf4et613	50	8	community	community	NN
cord-015493-vf4et613	50	9	-	-	HYPH
cord-015493-vf4et613	50	10	acquired	acquire	VBN
cord-015493-vf4et613	50	11	MRSA	MRSA	NNP
cord-015493-vf4et613	50	12	is	be	VBZ
cord-015493-vf4et613	50	13	a	a	DT
cord-015493-vf4et613	50	14	moving	move	VBG
cord-015493-vf4et613	50	15	target	target	NN
cord-015493-vf4et613	50	16	,	,	,
cord-015493-vf4et613	50	17	and	and	CC
cord-015493-vf4et613	50	18	that	that	IN
cord-015493-vf4et613	50	19	,	,	,
cord-015493-vf4et613	50	20	in	in	IN
cord-015493-vf4et613	50	21	some	some	DT
cord-015493-vf4et613	50	22	geographical	geographical	JJ
cord-015493-vf4et613	50	23	areas	area	NNS
cord-015493-vf4et613	50	24	,	,	,
cord-015493-vf4et613	50	25	it	-PRON-	PRP
cord-015493-vf4et613	50	26	has	have	VBZ
cord-015493-vf4et613	50	27	acquired	acquire	VBN
cord-015493-vf4et613	50	28	additional	additional	JJ
cord-015493-vf4et613	50	29	antibiotic	antibiotic	JJ
cord-015493-vf4et613	50	30	-	-	HYPH
cord-015493-vf4et613	50	31	resistance	resistance	NN
cord-015493-vf4et613	50	32	determinants	determinant	NNS
cord-015493-vf4et613	50	33	.	.	.
cord-015493-vf4et613	51	1	An	an	DT
cord-015493-vf4et613	51	2	additional	additional	JJ
cord-015493-vf4et613	51	3	factor	factor	NN
cord-015493-vf4et613	51	4	that	that	WDT
cord-015493-vf4et613	51	5	must	must	MD
cord-015493-vf4et613	51	6	be	be	VB
cord-015493-vf4et613	51	7	considered	consider	VBN
cord-015493-vf4et613	51	8	in	in	IN
cord-015493-vf4et613	51	9	future	future	JJ
cord-015493-vf4et613	51	10	trials	trial	NNS
cord-015493-vf4et613	51	11	is	be	VBZ
cord-015493-vf4et613	51	12	the	the	DT
cord-015493-vf4et613	51	13	potential	potential	JJ
cord-015493-vf4et613	51	14	benefit	benefit	NN
cord-015493-vf4et613	51	15	of	of	IN
cord-015493-vf4et613	51	16	effective	effective	JJ
cord-015493-vf4et613	51	17	antibiotic	antibiotic	JJ
cord-015493-vf4et613	51	18	therapy	therapy	NN
cord-015493-vf4et613	51	19	on	on	IN
cord-015493-vf4et613	51	20	the	the	DT
cord-015493-vf4et613	51	21	prevention	prevention	NN
cord-015493-vf4et613	51	22	or	or	CC
cord-015493-vf4et613	51	23	delay	delay	NN
cord-015493-vf4et613	51	24	of	of	IN
cord-015493-vf4et613	51	25	recurrences	recurrence	NNS
cord-015493-vf4et613	51	26	of	of	IN
cord-015493-vf4et613	51	27	infection	infection	NN
cord-015493-vf4et613	51	28	.	.	.
cord-015493-vf4et613	52	1	Identification	identification	NN
cord-015493-vf4et613	52	2	of	of	IN
cord-015493-vf4et613	52	3	a	a	DT
cord-015493-vf4et613	52	4	third	third	JJ
cord-015493-vf4et613	52	5	human	human	JJ
cord-015493-vf4et613	52	6	polyomavirus	polyomavirus	JJ
cord-015493-vf4et613	52	7	Characterization	characterization	NN
cord-015493-vf4et613	52	8	of	of	IN
cord-015493-vf4et613	52	9	a	a	DT
cord-015493-vf4et613	52	10	newly	newly	RB
cord-015493-vf4et613	52	11	identified	identify	VBN
cord-015493-vf4et613	52	12	human	human	JJ
cord-015493-vf4et613	52	13	rhinovirus	rhinovirus	NN
cord-015493-vf4et613	52	14	,	,	,
cord-015493-vf4et613	52	15	HRV	HRV	NNP
cord-015493-vf4et613	52	16	-	-	HYPH
cord-015493-vf4et613	52	17	QPM	QPM	NNP
cord-015493-vf4et613	52	18	,	,	,
cord-015493-vf4et613	52	19	discovered	discover	VBN
cord-015493-vf4et613	52	20	in	in	IN
cord-015493-vf4et613	52	21	infants	infant	NNS
cord-015493-vf4et613	52	22	with	with	IN
cord-015493-vf4et613	52	23	bronchiolitis	bronchiolitis	NN
cord-015493-vf4et613	52	24	Community	community	NN
cord-015493-vf4et613	52	25	-	-	HYPH
cord-015493-vf4et613	52	26	onset	onset	NN
cord-015493-vf4et613	52	27	methicillin	methicillin	NN
cord-015493-vf4et613	52	28	-	-	HYPH
cord-015493-vf4et613	52	29	resistant	resistant	JJ
cord-015493-vf4et613	52	30	Staphylococcus	Staphylococcus	NNP
cord-015493-vf4et613	52	31	aureus	aureus	NN
cord-015493-vf4et613	52	32	skin	skin	NN
cord-015493-vf4et613	52	33	and	and	CC
cord-015493-vf4et613	52	34	soft	soft	JJ
cord-015493-vf4et613	52	35	-	-	HYPH
cord-015493-vf4et613	52	36	tissue	tissue	NN
cord-015493-vf4et613	52	37	infections	infection	NNS
cord-015493-vf4et613	52	38	:	:	:
cord-015493-vf4et613	52	39	impact	impact	NN
cord-015493-vf4et613	52	40	of	of	IN
cord-015493-vf4et613	52	41	antimicrobial	antimicrobial	JJ
cord-015493-vf4et613	52	42	therapy	therapy	NN
cord-015493-vf4et613	52	43	on	on	IN
cord-015493-vf4et613	52	44	outcome	outcome	NN
cord-015493-vf4et613	52	45	Prospective	prospective	JJ
cord-015493-vf4et613	52	46	randomized	randomized	JJ
cord-015493-vf4et613	52	47	trial	trial	NN
cord-015493-vf4et613	52	48	of	of	IN
cord-015493-vf4et613	52	49	empiric	empiric	JJ
cord-015493-vf4et613	52	50	therapy	therapy	NN
cord-015493-vf4et613	52	51	with	with	IN
cord-015493-vf4et613	52	52	trimethoprim	trimethoprim	NNP
cord-015493-vf4et613	52	53	-	-	HYPH
cord-015493-vf4et613	52	54	sulfamethoxazole	sulfamethoxazole	NNP
cord-015493-vf4et613	52	55	or	or	CC
cord-015493-vf4et613	52	56	doxycycline	doxycycline	NN
cord-015493-vf4et613	52	57	for	for	IN
cord-015493-vf4et613	52	58	outpatient	outpatient	NN
cord-015493-vf4et613	52	59	skin	skin	NN
cord-015493-vf4et613	52	60	and	and	CC
cord-015493-vf4et613	52	61	soft	soft	JJ
cord-015493-vf4et613	52	62	tissue	tissue	NN
cord-015493-vf4et613	52	63	infections	infection	NNS
cord-015493-vf4et613	52	64	in	in	IN
cord-015493-vf4et613	52	65	an	an	DT
cord-015493-vf4et613	52	66	area	area	NN
cord-015493-vf4et613	52	67	of	of	IN
cord-015493-vf4et613	52	68	high	high	JJ
cord-015493-vf4et613	52	69	prevalence	prevalence	NN
cord-015493-vf4et613	52	70	of	of	IN
cord-015493-vf4et613	52	71	methicillin	methicillin	NN
cord-015493-vf4et613	52	72	-	-	HYPH
cord-015493-vf4et613	52	73	resistant	resistant	JJ
cord-015493-vf4et613	52	74	Staphylococcus	Staphylococcus	NNP
cord-015493-vf4et613	52	75	aureus	aureus	NN
cord-015493-vf4et613	53	1	In	in	IN
cord-015493-vf4et613	53	2	the	the	DT
cord-015493-vf4et613	53	3	literature	literature	NN
cord-015493-vf4et613	53	4	:	:	:
cord-015493-vf4et613	53	5	Chlamydia	Chlamydia	NNP
cord-015493-vf4et613	53	6	trachomatis	trachomatis	NN
cord-015493-vf4et613	53	7	finds	find	VBZ
cord-015493-vf4et613	53	8	a	a	DT
cord-015493-vf4et613	53	9	way	way	NN
cord-015493-vf4et613	53	10	to	to	TO
cord-015493-vf4et613	53	11	evade	evade	VB
cord-015493-vf4et613	53	12	diagnosis	diagnosis	NN
cord-015493-vf4et613	53	13	Screening	screening	NN
cord-015493-vf4et613	53	14	for	for	IN
cord-015493-vf4et613	53	15	chlamydial	chlamydial	JJ
cord-015493-vf4et613	53	16	infection	infection	NN
cord-015493-vf4et613	53	17	:	:	:
cord-015493-vf4et613	53	18	US	US	NNP
cord-015493-vf4et613	53	19	Preventive	Preventive	NNP
cord-015493-vf4et613	53	20	Services	Services	NNPS
cord-015493-vf4et613	53	21	Task	Task	NNP
cord-015493-vf4et613	53	22	Force	Force	NNP
cord-015493-vf4et613	53	23	Recommendation	Recommendation	NNP
cord-015493-vf4et613	53	24	Statement	Statement	NNP
cord-015493-vf4et613	54	1	The	the	DT
cord-015493-vf4et613	54	2	most	most	RBS
cord-015493-vf4et613	54	3	frequently	frequently	RB
cord-015493-vf4et613	54	4	reported	report	VBN
cord-015493-vf4et613	54	5	notifiable	notifiable	JJ
cord-015493-vf4et613	54	6	disease	disease	NN
cord-015493-vf4et613	54	7	in	in	IN
cord-015493-vf4et613	54	8	the	the	DT
cord-015493-vf4et613	54	9	United	United	NNP
cord-015493-vf4et613	54	10	States	States	NNP
cord-015493-vf4et613	54	11	is	be	VBZ
cord-015493-vf4et613	54	12	infection	infection	NN
cord-015493-vf4et613	54	13	with	with	IN
cord-015493-vf4et613	54	14	Chlamydia	Chlamydia	NNP
cord-015493-vf4et613	54	15	trachomatis	trachomatis	NN
cord-015493-vf4et613	54	16	,	,	,
cord-015493-vf4et613	54	17	with	with	IN
cord-015493-vf4et613	54	18	Neisseria	Neisseria	NNP
cord-015493-vf4et613	54	19	gonorrhoeae	gonorrhoeae	NNP
cord-015493-vf4et613	54	20	infection	infection	NN
cord-015493-vf4et613	54	21	placing	place	VBG
cord-015493-vf4et613	54	22	second	second	RB
cord-015493-vf4et613	54	23	.	.	.
cord-015493-vf4et613	55	1	Urine	urine	NN
cord-015493-vf4et613	55	2	specimens	specimen	NNS
cord-015493-vf4et613	55	3	were	be	VBD
cord-015493-vf4et613	55	4	obtained	obtain	VBN
cord-015493-vf4et613	55	5	from	from	IN
cord-015493-vf4et613	55	6	6632	6632	CD
cord-015493-vf4et613	55	7	participants	participant	NNS
cord-015493-vf4et613	55	8	(	(	-LRB-
cord-015493-vf4et613	55	9	age	age	NN
cord-015493-vf4et613	55	10	,	,	,
cord-015493-vf4et613	55	11	14	14	CD
cord-015493-vf4et613	55	12	-	-	SYM
cord-015493-vf4et613	55	13	39	39	CD
cord-015493-vf4et613	55	14	years	year	NNS
cord-015493-vf4et613	55	15	)	)	-RRB-
cord-015493-vf4et613	55	16	during	during	IN
cord-015493-vf4et613	55	17	the	the	DT
cord-015493-vf4et613	55	18	period	period	NN
cord-015493-vf4et613	55	19	1999	1999	CD
cord-015493-vf4et613	55	20	-	-	SYM
cord-015493-vf4et613	55	21	2002	2002	CD
cord-015493-vf4et613	55	22	in	in	IN
cord-015493-vf4et613	55	23	the	the	DT
cord-015493-vf4et613	55	24	National	National	NNP
cord-015493-vf4et613	55	25	Health	Health	NNP
cord-015493-vf4et613	55	26	and	and	CC
cord-015493-vf4et613	55	27	Examination	Examination	NNP
cord-015493-vf4et613	55	28	Survey	Survey	NNP
cord-015493-vf4et613	55	29	;	;	,
cord-015493-vf4et613	55	30	ligase	ligase	NN
cord-015493-vf4et613	55	31	chain	chain	NN
cord-015493-vf4et613	55	32	reaction	reaction	NN
cord-015493-vf4et613	55	33	detected	detect	VBD
cord-015493-vf4et613	55	34	a	a	DT
cord-015493-vf4et613	55	35	prevalence	prevalence	NN
cord-015493-vf4et613	55	36	of	of	IN
cord-015493-vf4et613	55	37	chlamydial	chlamydial	JJ
cord-015493-vf4et613	55	38	infection	infection	NN
cord-015493-vf4et613	55	39	of	of	IN
cord-015493-vf4et613	55	40	2.2	2.2	CD
cord-015493-vf4et613	55	41	%	%	NN
cord-015493-vf4et613	55	42	(	(	-LRB-
cord-015493-vf4et613	55	43	95	95	CD
cord-015493-vf4et613	55	44	%	%	NN
cord-015493-vf4et613	55	45	CI	CI	NNP
cord-015493-vf4et613	55	46	,	,	,
cord-015493-vf4et613	55	47	1.8%-2.8	1.8%-2.8	CD
cord-015493-vf4et613	55	48	%	%	NN
cord-015493-vf4et613	55	49	)	)	-RRB-
cord-015493-vf4et613	55	50	and	and	CC
cord-015493-vf4et613	55	51	a	a	DT
cord-015493-vf4et613	55	52	prevalence	prevalence	NN
cord-015493-vf4et613	55	53	of	of	IN
cord-015493-vf4et613	55	54	gonorrheal	gonorrheal	JJ
cord-015493-vf4et613	55	55	infection	infection	NN
cord-015493-vf4et613	55	56	of	of	IN
cord-015493-vf4et613	55	57	0.24	0.24	CD
cord-015493-vf4et613	55	58	%	%	NN
cord-015493-vf4et613	55	59	(	(	-LRB-
cord-015493-vf4et613	55	60	95	95	CD
cord-015493-vf4et613	55	61	%	%	NN
cord-015493-vf4et613	55	62	CI	CI	NNP
cord-015493-vf4et613	55	63	,	,	,
cord-015493-vf4et613	55	64	0.16%-0.38	0.16%-0.38	CD
cord-015493-vf4et613	55	65	%	%	NN
cord-015493-vf4et613	55	66	)	)	-RRB-
cord-015493-vf4et613	55	67	.	.	.
cord-015493-vf4et613	56	1	The	the	DT
cord-015493-vf4et613	56	2	prevalence	prevalence	NN
cord-015493-vf4et613	56	3	of	of	IN
cord-015493-vf4et613	56	4	chlamydial	chlamydial	JJ
cord-015493-vf4et613	56	5	infection	infection	NN
cord-015493-vf4et613	56	6	was	be	VBD
cord-015493-vf4et613	56	7	similar	similar	JJ
cord-015493-vf4et613	56	8	in	in	IN
cord-015493-vf4et613	56	9	male	male	JJ
cord-015493-vf4et613	56	10	and	and	CC
cord-015493-vf4et613	56	11	female	female	JJ
cord-015493-vf4et613	56	12	subjects	subject	NNS
cord-015493-vf4et613	56	13	but	but	CC
cord-015493-vf4et613	56	14	peaked	peak	VBD
cord-015493-vf4et613	56	15	at	at	IN
cord-015493-vf4et613	56	16	the	the	DT
cord-015493-vf4et613	56	17	ages	age	NNS
cord-015493-vf4et613	56	18	of	of	IN
cord-015493-vf4et613	56	19	14	14	CD
cord-015493-vf4et613	56	20	-	-	SYM
cord-015493-vf4et613	56	21	19	19	CD
cord-015493-vf4et613	56	22	years	year	NNS
cord-015493-vf4et613	56	23	in	in	IN
cord-015493-vf4et613	56	24	female	female	JJ
cord-015493-vf4et613	56	25	subjects	subject	NNS
cord-015493-vf4et613	56	26	and	and	CC
cord-015493-vf4et613	56	27	14	14	CD
cord-015493-vf4et613	56	28	-	-	SYM
cord-015493-vf4et613	56	29	29	29	CD
cord-015493-vf4et613	56	30	years	year	NNS
cord-015493-vf4et613	56	31	in	in	IN
cord-015493-vf4et613	56	32	male	male	JJ
cord-015493-vf4et613	56	33	subjects	subject	NNS
cord-015493-vf4et613	56	34	.	.	.
cord-015493-vf4et613	57	1	The	the	DT
cord-015493-vf4et613	57	2	prevalence	prevalence	NN
cord-015493-vf4et613	57	3	was	be	VBD
cord-015493-vf4et613	57	4	higher	high	JJR
cord-015493-vf4et613	57	5	among	among	IN
cord-015493-vf4et613	57	6	non	non	JJ
cord-015493-vf4et613	57	7	-	-	JJ
cord-015493-vf4et613	57	8	Hispanic	hispanic	JJ
cord-015493-vf4et613	57	9	black	black	JJ
cord-015493-vf4et613	57	10	sub	sub	NN
cord-015493-vf4et613	57	11	-	-	JJ
cord-015493-vf4et613	57	12	jects	ject	NNS
cord-015493-vf4et613	57	13	(	(	-LRB-
cord-015493-vf4et613	57	14	6.4	6.4	CD
cord-015493-vf4et613	57	15	%	%	NN
cord-015493-vf4et613	57	16	)	)	-RRB-
cord-015493-vf4et613	57	17	than	than	IN
cord-015493-vf4et613	57	18	among	among	IN
cord-015493-vf4et613	57	19	non	non	JJ
cord-015493-vf4et613	57	20	-	-	JJ
cord-015493-vf4et613	57	21	Hispanic	hispanic	JJ
cord-015493-vf4et613	57	22	white	white	JJ
cord-015493-vf4et613	57	23	subjects	subject	NNS
cord-015493-vf4et613	57	24	(	(	-LRB-
cord-015493-vf4et613	57	25	1.5	1.5	CD
cord-015493-vf4et613	57	26	%	%	NN
cord-015493-vf4et613	57	27	)	)	-RRB-
cord-015493-vf4et613	57	28	.	.	.
cord-015493-vf4et613	58	1	The	the	DT
cord-015493-vf4et613	58	2	prevalence	prevalence	NN
cord-015493-vf4et613	58	3	of	of	IN
cord-015493-vf4et613	58	4	gonorrheal	gonorrheal	NN
cord-015493-vf4et613	58	5	infection	infection	NN
cord-015493-vf4et613	58	6	was	be	VBD
cord-015493-vf4et613	58	7	also	also	RB
cord-015493-vf4et613	58	8	higher	high	JJR
cord-015493-vf4et613	58	9	in	in	IN
cord-015493-vf4et613	58	10	non	non	JJ
cord-015493-vf4et613	58	11	-	-	JJ
cord-015493-vf4et613	58	12	Hispanic	hispanic	JJ
cord-015493-vf4et613	58	13	blacks	black	NNS
cord-015493-vf4et613	58	14	(	(	-LRB-
cord-015493-vf4et613	58	15	1.2	1.2	CD
cord-015493-vf4et613	58	16	%	%	NN
cord-015493-vf4et613	58	17	vs.	vs.	CC
cord-015493-vf4et613	58	18	0.07	0.07	CD
cord-015493-vf4et613	58	19	%	%	NN
cord-015493-vf4et613	58	20	)	)	-RRB-
cord-015493-vf4et613	58	21	.	.	.
cord-015493-vf4et613	59	1	Forty	forty	CD
cord-015493-vf4et613	59	2	-	-	HYPH
cord-015493-vf4et613	59	3	six	six	CD
cord-015493-vf4et613	59	4	percent	percent	NN
cord-015493-vf4et613	59	5	of	of	IN
cord-015493-vf4et613	59	6	individuals	individual	NNS
cord-015493-vf4et613	59	7	with	with	IN
cord-015493-vf4et613	59	8	gonorrheal	gonorrheal	JJ
cord-015493-vf4et613	59	9	infection	infection	NN
cord-015493-vf4et613	59	10	were	be	VBD
cord-015493-vf4et613	59	11	coinfected	coinfecte	VBN
cord-015493-vf4et613	59	12	with	with	IN
cord-015493-vf4et613	59	13	C.	C.	NNP
cord-015493-vf4et613	59	14	trachomatis	trachomatis	NN
cord-015493-vf4et613	59	15	.	.	.
cord-015493-vf4et613	60	1	It	-PRON-	PRP
cord-015493-vf4et613	60	2	should	should	MD
cord-015493-vf4et613	60	3	be	be	VB
cord-015493-vf4et613	60	4	noted	note	VBN
cord-015493-vf4et613	60	5	that	that	IN
cord-015493-vf4et613	60	6	the	the	DT
cord-015493-vf4et613	60	7	test	test	NN
cord-015493-vf4et613	60	8	used	use	VBN
cord-015493-vf4et613	60	9	in	in	IN
cord-015493-vf4et613	60	10	this	this	DT
cord-015493-vf4et613	60	11	survey	survey	NN
cord-015493-vf4et613	60	12	targets	target	VBZ
cord-015493-vf4et613	60	13	a	a	DT
cord-015493-vf4et613	60	14	portion	portion	NN
cord-015493-vf4et613	60	15	of	of	IN
cord-015493-vf4et613	60	16	a	a	DT
cord-015493-vf4et613	60	17	cryptic	cryptic	JJ
cord-015493-vf4et613	60	18	plasmid	plasmid	NN
cord-015493-vf4et613	60	19	in	in	IN
cord-015493-vf4et613	60	20	C.	C.	NNP
cord-015493-vf4et613	60	21	trachomatis	trachomatis	NN
cord-015493-vf4et613	60	22	that	that	WDT
cord-015493-vf4et613	60	23	has	have	VBZ
cord-015493-vf4et613	60	24	been	be	VBN
cord-015493-vf4et613	60	25	lost	lose	VBN
cord-015493-vf4et613	60	26	by	by	IN
cord-015493-vf4et613	60	27	some	some	DT
cord-015493-vf4et613	60	28	isolates	isolate	NNS
cord-015493-vf4et613	60	29	in	in	IN
cord-015493-vf4et613	60	30	Sweden	Sweden	NNP
cord-015493-vf4et613	60	31	,	,	,
cord-015493-vf4et613	60	32	leading	lead	VBG
cord-015493-vf4et613	60	33	to	to	IN
cord-015493-vf4et613	60	34	false	false	JJ
cord-015493-vf4et613	60	35	-	-	HYPH
cord-015493-vf4et613	60	36	negative	negative	JJ
cord-015493-vf4et613	60	37	results	result	NNS
cord-015493-vf4et613	60	38	[	[	-LRB-
cord-015493-vf4et613	60	39	1	1	CD
cord-015493-vf4et613	60	40	]	]	-RRB-
cord-015493-vf4et613	60	41	.	.	.
cord-015493-vf4et613	61	1	Although	although	IN
cord-015493-vf4et613	61	2	this	this	DT
cord-015493-vf4et613	61	3	is	be	VBZ
cord-015493-vf4et613	61	4	not	not	RB
cord-015493-vf4et613	61	5	likely	likely	JJ
cord-015493-vf4et613	61	6	to	to	TO
cord-015493-vf4et613	61	7	have	have	VB
cord-015493-vf4et613	61	8	affected	affect	VBN
cord-015493-vf4et613	61	9	the	the	DT
cord-015493-vf4et613	61	10	results	result	NNS
cord-015493-vf4et613	61	11	of	of	IN
cord-015493-vf4et613	61	12	this	this	DT
cord-015493-vf4et613	61	13	study	study	NN
cord-015493-vf4et613	61	14	,	,	,
cord-015493-vf4et613	61	15	it	-PRON-	PRP
cord-015493-vf4et613	61	16	is	be	VBZ
cord-015493-vf4et613	61	17	an	an	DT
cord-015493-vf4et613	61	18	issue	issue	NN
cord-015493-vf4et613	61	19	that	that	WDT
cord-015493-vf4et613	61	20	may	may	MD
cord-015493-vf4et613	61	21	have	have	VB
cord-015493-vf4et613	61	22	to	to	TO
cord-015493-vf4et613	61	23	addressed	address	VBN
cord-015493-vf4et613	61	24	in	in	IN
cord-015493-vf4et613	61	25	the	the	DT
cord-015493-vf4et613	61	26	future	future	NN
cord-015493-vf4et613	61	27	.	.	.
cord-015493-vf4et613	62	1	The	the	DT
cord-015493-vf4et613	62	2	authors	author	NNS
cord-015493-vf4et613	62	3	point	point	VBP
cord-015493-vf4et613	62	4	out	out	RP
cord-015493-vf4et613	62	5	that	that	IN
cord-015493-vf4et613	62	6	these	these	DT
cord-015493-vf4et613	62	7	data	datum	NNS
cord-015493-vf4et613	62	8	support	support	VBP
cord-015493-vf4et613	62	9	current	current	JJ
cord-015493-vf4et613	62	10	recommendations	recommendation	NNS
cord-015493-vf4et613	62	11	for	for	IN
cord-015493-vf4et613	62	12	screening	screen	VBG
cord-015493-vf4et613	62	13	sexually	sexually	RB
cord-015493-vf4et613	62	14	active	active	JJ
cord-015493-vf4et613	62	15	females	female	NNS
cord-015493-vf4et613	63	1	aged	aged	JJ
cord-015493-vf4et613	63	2	р25	р25	DT
cord-015493-vf4et613	63	3	years	year	NNS
cord-015493-vf4et613	63	4	for	for	IN
cord-015493-vf4et613	63	5	chlamydial	chlamydial	JJ
cord-015493-vf4et613	63	6	infection	infection	NN
cord-015493-vf4et613	63	7	and	and	CC
cord-015493-vf4et613	63	8	for	for	IN
cord-015493-vf4et613	63	9	coadministration	coadministration	NN
cord-015493-vf4et613	63	10	of	of	IN
cord-015493-vf4et613	63	11	treatment	treatment	NN
cord-015493-vf4et613	63	12	for	for	IN
cord-015493-vf4et613	63	13	C.	C.	NNP
cord-015493-vf4et613	63	14	trachomatis	trachomatis	NN
cord-015493-vf4et613	63	15	infection	infection	NN
cord-015493-vf4et613	63	16	in	in	IN
cord-015493-vf4et613	63	17	patients	patient	NNS
cord-015493-vf4et613	63	18	with	with	IN
cord-015493-vf4et613	63	19	gonorrheal	gonorrheal	JJ
cord-015493-vf4et613	63	20	infection	infection	NN
cord-015493-vf4et613	63	21	,	,	,
cord-015493-vf4et613	63	22	unless	unless	IN
cord-015493-vf4et613	63	23	the	the	DT
cord-015493-vf4et613	63	24	former	former	JJ
cord-015493-vf4et613	63	25	has	have	VBZ
cord-015493-vf4et613	63	26	been	be	VBN
cord-015493-vf4et613	63	27	ruled	rule	VBN
cord-015493-vf4et613	63	28	out	out	RP
cord-015493-vf4et613	63	29	[	[	-LRB-
cord-015493-vf4et613	63	30	2	2	CD
cord-015493-vf4et613	63	31	]	]	-RRB-
cord-015493-vf4et613	63	32	.	.	.
cord-015493-vf4et613	64	1	The	the	DT
cord-015493-vf4et613	64	2	following	follow	VBG
cord-015493-vf4et613	64	3	is	be	VBZ
cord-015493-vf4et613	64	4	a	a	DT
cord-015493-vf4et613	64	5	summary	summary	NN
cord-015493-vf4et613	64	6	of	of	IN
cord-015493-vf4et613	64	7	current	current	JJ
cord-015493-vf4et613	64	8	recommendations	recommendation	NNS
cord-015493-vf4et613	64	9	for	for	IN
cord-015493-vf4et613	64	10	screening	screen	VBG
cord-015493-vf4et613	64	11	[	[	-LRB-
cord-015493-vf4et613	64	12	2	2	CD
cord-015493-vf4et613	64	13	]	]	-RRB-
cord-015493-vf4et613	64	14	:	:	:
cord-015493-vf4et613	65	1	•	•	NNP
cord-015493-vf4et613	65	2	Screen	screen	NN
cord-015493-vf4et613	65	3	for	for	IN
cord-015493-vf4et613	65	4	chlamydial	chlamydial	JJ
cord-015493-vf4et613	65	5	infection	infection	NN
cord-015493-vf4et613	65	6	in	in	IN
cord-015493-vf4et613	65	7	all	all	DT
cord-015493-vf4et613	65	8	sexually	sexually	RB
cord-015493-vf4et613	65	9	active	active	JJ
cord-015493-vf4et613	65	10	,	,	,
cord-015493-vf4et613	65	11	nonpregnant	nonpregnant	JJ
cord-015493-vf4et613	65	12	,	,	,
cord-015493-vf4et613	65	13	young	young	JJ
cord-015493-vf4et613	65	14	women	woman	NNS
cord-015493-vf4et613	65	15	(	(	-LRB-
cord-015493-vf4et613	65	16	age	age	NN
cord-015493-vf4et613	65	17	,	,	,
cord-015493-vf4et613	65	18	р24	р24	CD
cord-015493-vf4et613	65	19	years	year	NNS
cord-015493-vf4et613	65	20	)	)	-RRB-
cord-015493-vf4et613	65	21	and	and	CC
cord-015493-vf4et613	65	22	in	in	IN
cord-015493-vf4et613	65	23	older	old	JJR
cord-015493-vf4et613	65	24	,	,	,
cord-015493-vf4et613	65	25	nonpregnant	nonpregnant	JJ
cord-015493-vf4et613	65	26	women	woman	NNS
cord-015493-vf4et613	65	27	who	who	WP
cord-015493-vf4et613	65	28	are	be	VBP
cord-015493-vf4et613	65	29	at	at	IN
cord-015493-vf4et613	65	30	increased	increase	VBN
cord-015493-vf4et613	65	31	risk.•	risk.•	NNP
cord-015493-vf4et613	65	32	Screen	Screen	NNP
cord-015493-vf4et613	65	33	for	for	IN
cord-015493-vf4et613	65	34	chlamydial	chlamydial	JJ
cord-015493-vf4et613	65	35	infection	infection	NN
cord-015493-vf4et613	65	36	in	in	IN
cord-015493-vf4et613	65	37	all	all	DT
cord-015493-vf4et613	65	38	pregnant	pregnant	JJ
cord-015493-vf4et613	65	39	women	woman	NNS
cord-015493-vf4et613	65	40	aged	age	VBN
cord-015493-vf4et613	65	41	р24	р24	NNP
cord-015493-vf4et613	65	42	years	year	NNS
cord-015493-vf4et613	65	43	and	and	CC
cord-015493-vf4et613	65	44	in	in	IN
cord-015493-vf4et613	65	45	older	old	JJR
cord-015493-vf4et613	65	46	,	,	,
cord-015493-vf4et613	65	47	pregnant	pregnant	JJ
cord-015493-vf4et613	65	48	women	woman	NNS
cord-015493-vf4et613	65	49	who	who	WP
cord-015493-vf4et613	65	50	are	be	VBP
cord-015493-vf4et613	65	51	at	at	IN
cord-015493-vf4et613	65	52	increased	increase	VBN
cord-015493-vf4et613	65	53	risk.•	risk.•	NNP
cord-015493-vf4et613	65	54	Do	do	VB
cord-015493-vf4et613	65	55	not	not	RB
cord-015493-vf4et613	65	56	routinely	routinely	RB
cord-015493-vf4et613	65	57	screen	screen	VB
cord-015493-vf4et613	65	58	for	for	IN
cord-015493-vf4et613	65	59	chlamydial	chlamydial	JJ
cord-015493-vf4et613	65	60	infection	infection	NN
cord-015493-vf4et613	65	61	in	in	IN
cord-015493-vf4et613	65	62	women	woman	NNS
cord-015493-vf4et613	66	1	aged	aged	JJ
cord-015493-vf4et613	66	2	у25	у25	CD
cord-015493-vf4et613	66	3	years	year	NNS
cord-015493-vf4et613	66	4	,	,	,
cord-015493-vf4et613	66	5	regardless	regardless	RB
cord-015493-vf4et613	66	6	of	of	IN
cord-015493-vf4et613	66	7	whether	whether	IN
cord-015493-vf4et613	66	8	they	-PRON-	PRP
cord-015493-vf4et613	66	9	are	be	VBP
cord-015493-vf4et613	66	10	pregnant	pregnant	JJ
cord-015493-vf4et613	66	11	,	,	,
cord-015493-vf4et613	66	12	if	if	IN
cord-015493-vf4et613	66	13	they	-PRON-	PRP
cord-015493-vf4et613	66	14	are	be	VBP
cord-015493-vf4et613	66	15	not	not	RB
cord-015493-vf4et613	66	16	at	at	IN
cord-015493-vf4et613	66	17	increased	increase	VBN
cord-015493-vf4et613	66	18	risk.•	risk.•	NNP
cord-015493-vf4et613	66	19	Current	current	JJ
cord-015493-vf4et613	66	20	evidence	evidence	NN
cord-015493-vf4et613	66	21	is	be	VBZ
cord-015493-vf4et613	66	22	insufficient	insufficient	JJ
cord-015493-vf4et613	66	23	to	to	TO
cord-015493-vf4et613	66	24	assess	assess	VB
cord-015493-vf4et613	66	25	the	the	DT
cord-015493-vf4et613	66	26	balance	balance	NN
cord-015493-vf4et613	66	27	of	of	IN
cord-015493-vf4et613	66	28	benefits	benefit	NNS
cord-015493-vf4et613	66	29	and	and	CC
cord-015493-vf4et613	66	30	harms	harm	NNS
cord-015493-vf4et613	66	31	of	of	IN
cord-015493-vf4et613	66	32	screening	screening	NN
cord-015493-vf4et613	66	33	for	for	IN
cord-015493-vf4et613	66	34	chlamydial	chlamydial	JJ
cord-015493-vf4et613	66	35	infection	infection	NN
cord-015493-vf4et613	66	36	in	in	IN
cord-015493-vf4et613	66	37	men	man	NNS
cord-015493-vf4et613	66	38	.	.	.